<!DOCTYPE html>
<!--[if lt IE 7]><html lang="tr" xmlns:fb="https://www.facebook.com/2008/fbml" xmlns:addthis="https://www.addthis.com/help/api-spec"  class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if (IE 7)&!(IEMobile)]><html lang="tr" xmlns:fb="https://www.facebook.com/2008/fbml" xmlns:addthis="https://www.addthis.com/help/api-spec"  class="no-js lt-ie9 lt-ie8"><![endif]-->
<!--[if (IE 8)&!(IEMobile)]><html lang="tr" xmlns:fb="https://www.facebook.com/2008/fbml" xmlns:addthis="https://www.addthis.com/help/api-spec"  class="no-js lt-ie9"><![endif]-->
<!--[if gt IE 8]><!--> <html lang="tr" xmlns:fb="https://www.facebook.com/2008/fbml" xmlns:addthis="https://www.addthis.com/help/api-spec" class="no-js"><!--<![endif]-->
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app202.us.archive.org';v.server_ms=422;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/_static/js/playback.bundle.js?v=xTFGO54E" charset="utf-8"></script>
<script type="text/javascript" src="/_static/js/wombat.js?v=UHAOicsW" charset="utf-8"></script>
<script type="text/javascript">
  __wm.init("https://web.archive.org/web");
  __wm.wombat("https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/","20200507111614","https://web.archive.org/","web","/_static/",
	      "1588850174");
</script>
<link rel="stylesheet" type="text/css" href="/_static/css/banner-styles.css?v=omkqRugM" />
<link rel="stylesheet" type="text/css" href="/_static/css/iconochive.css?v=qtvMKcIJ" />
<!-- End Wayback Rewrite JS Include -->

<meta charset="utf-8">

<!--[if IE]><meta http-equiv="X-UA-Compatible" content="IE=edge" /><![endif]-->

<meta name="viewport" content="width=device-width, initial-scale=1.0"/>
<meta name="test" content="test"/>
<meta property="og:ttl" content="345600"/>
<link rel="pingback" href="https://teyit.org/xmlrpc.php">

<title>Covid-19 tedavisinde denenen ilaç ve aşı çalışmaları ne durumda? - teyit.org</title>

<meta name="google-site-verification" content="Gip_3JEGhdlZhzB5ygO8XSCUbru3pdP8_fK5rQyuf48"/>

<meta name="description" content="Tüm dünyanın Covid-19 tedavisi için merakla beklediği ve umut bağladığı bir mesele var: Salgını durdurabilecek yani virüsü yenebilecek bir aşı ya da ilacın geliştirilebilmesi. Peki dünyada aşı ve ilaç çalışmaları ne durumda?"/>
<link rel="canonical" href="https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/"/>
<meta property="og:locale" content="tr_TR"/>
<meta property="og:type" content="article"/>
<meta property="og:title" content="Covid-19 tedavisinde denenen ilaç ve aşı çalışmaları ne durumda? - teyit.org"/>
<meta property="og:description" content="Tüm dünyanın Covid-19 tedavisi için merakla beklediği ve umut bağladığı bir mesele var: Salgını durdurabilecek yani virüsü yenebilecek bir aşı ya da ilacın geliştirilebilmesi. Peki dünyada aşı ve ilaç çalışmaları ne durumda?"/>
<meta property="og:url" content="https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/"/>
<meta property="og:site_name" content="teyit.org"/>
<meta property="article:tag" content="Aşı"/>
<meta property="article:tag" content="Covid-19"/>
<meta property="article:tag" content="ilaç"/>
<meta property="article:tag" content="Koronavirüs"/>
<meta property="article:section" content="Büyüteç"/>
<meta property="article:published_time" content="2020-05-05T12:28:06+00:00"/>
<meta property="article:modified_time" content="2020-05-06T08:06:43+00:00"/>
<meta property="og:updated_time" content="2020-05-06T08:06:43+00:00"/>
<meta property="og:image" content="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/Covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda.png"/>
<meta property="og:image:secure_url" content="https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/Covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda.png"/>
<meta property="og:image:width" content="750"/>
<meta property="og:image:height" content="350"/>
<meta name="twitter:card" content="summary_large_image"/>
<meta name="twitter:description" content="Tüm dünyanın Covid-19 tedavisi için merakla beklediği ve umut bağladığı bir mesele var: Salgını durdurabilecek yani virüsü yenebilecek bir aşı ya da ilacın geliştirilebilmesi. Peki dünyada aşı ve ilaç çalışmaları ne durumda?"/>
<meta name="twitter:title" content="Covid-19 tedavisinde denenen ilaç ve aşı çalışmaları ne durumda? - teyit.org"/>
<meta name="twitter:image" content="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/Covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda.png"/>
<script type="application/ld+json" class="yoast-schema-graph yoast-schema-graph--main">{"@context":"https://web.archive.org/web/20200507111614/https://schema.org","@graph":[{"@type":"Organization","@id":"https://web.archive.org/web/20200507111614/https://teyit.org/#organization","name":"teyit.org","url":"https://web.archive.org/web/20200507111614/https://teyit.org/","sameAs":[],"logo":{"@type":"ImageObject","@id":"https://web.archive.org/web/20200507111614/https://teyit.org/#logo","url":"https://web.archive.org/web/20200507111614/https://teyit.org/wp-content/uploads/2019/01/teyit_amblem_siyah_300ppi.png","caption":"teyit.org"},"image":{"@id":"https://web.archive.org/web/20200507111614/https://teyit.org/#logo"}},{"@type":"WebSite","@id":"https://web.archive.org/web/20200507111614/https://teyit.org/#website","url":"https://web.archive.org/web/20200507111614/https://teyit.org/","name":"teyit.org","publisher":{"@id":"https://web.archive.org/web/20200507111614/https://teyit.org/#organization"},"potentialAction":{"@type":"SearchAction","target":"https://web.archive.org/web/20200507111614/https://teyit.org/?s={search_term_string}","query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/#webpage","url":"https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/","inLanguage":"tr","name":"Covid-19 tedavisinde denenen ila\u00e7 ve a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131 ne durumda? - teyit.org","isPartOf":{"@id":"https://web.archive.org/web/20200507111614/https://teyit.org/#website"},"image":{"@type":"ImageObject","@id":"https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/#primaryimage","url":"https://web.archive.org/web/20200507111614/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/Covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda.png","width":750,"height":350},"primaryImageOfPage":{"@id":"https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/#primaryimage"},"datePublished":"2020-05-05T12:28:06+00:00","dateModified":"2020-05-06T08:06:43+00:00","description":"T\u00fcm d\u00fcnyan\u0131n Covid-19 tedavisi i\u00e7in merakla bekledi\u011fi ve umut ba\u011flad\u0131\u011f\u0131 bir mesele var: Salg\u0131n\u0131 durdurabilecek yani vir\u00fcs\u00fc yenebilecek bir a\u015f\u0131 ya da ilac\u0131n geli\u015ftirilebilmesi.\u00a0Peki d\u00fcnyada a\u015f\u0131 ve ila\u00e7 \u00e7al\u0131\u015fmalar\u0131 ne durumda?"},{"@type":"Article","@id":"https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/#article","isPartOf":{"@id":"https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/#webpage"},"author":{"@id":"https://web.archive.org/web/20200507111614/https://teyit.org/author/ezgi/#author","name":"Ezgi Toprak"},"publisher":{"@id":"https://web.archive.org/web/20200507111614/https://teyit.org/#organization"},"headline":"Covid-19 tedavisinde denenen ila\u00e7 ve a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131 ne durumda?","datePublished":"2020-05-05T12:28:06+00:00","dateModified":"2020-05-06T08:06:43+00:00","commentCount":0,"mainEntityOfPage":"https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/#webpage","image":{"@id":"https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/#primaryimage"},"keywords":"A\u015f\u0131,Covid-19,ila\u00e7,Koronavir\u00fcs","articleSection":"B\u00fcy\u00fcte\u00e7,Dosya,Sa\u011fl\u0131k"},{"@type":"Person","@id":"https://web.archive.org/web/20200507111614/https://teyit.org/author/ezgi/#author","name":"Ezgi Toprak","image":{"@type":"ImageObject","@id":"https://web.archive.org/web/20200507111614/https://teyit.org/#personlogo","url":"https://web.archive.org/web/20200507111614/https://secure.gravatar.com/avatar/b87ff1754a7aefa1fe7a119fdaa699ce?s=96&d=https%3A%2F%2Fteyit.org%2Fwp-content%2Fuploads%2F2017%2F01%2Fgravatar-for-comments.png&r=g","caption":"Ezgi Toprak"},"description":"Anadolu \u00dcniversitesi \u0130leti\u015fim Bilimleri Fak\u00fcltesi Bas\u0131n ve Yay\u0131n b\u00f6l\u00fcm\u00fc mezunu. Ayn\u0131 \u00fcniversitenin Bas\u0131n ve Yay\u0131n Anabilim dal\u0131nda y\u00fcksek lisans\u0131na devam ediyor. Milliyet gazetesi ve CNN T\u00fcrk'te stajyerlik yapt\u0131. Bir yap\u0131m \u015firketinde edit\u00f6r olarak \u00e7al\u0131\u015ft\u0131. Siyasal ileti\u015fim ve yeni medya konular\u0131yla ilgileniyor.","sameAs":[]}]}</script>

<link rel="dns-prefetch" href="//web.archive.org/web/20200507111614/https://s7.addthis.com/"/>
<link rel="dns-prefetch" href="//web.archive.org/web/20200507111614/https://s0.wp.com/"/>
<link rel="dns-prefetch" href="//web.archive.org/web/20200507111614/https://apis.google.com/"/>
<link rel="dns-prefetch" href="//web.archive.org/web/20200507111614/https://fonts.googleapis.com/"/>
<link rel="dns-prefetch" href="//web.archive.org/web/20200507111614/https://s.w.org/"/>
<link rel="alternate" type="application/rss+xml" title="teyit.org » beslemesi" href="https://web.archive.org/web/20200507111614/https://teyit.org/feed/"/>
<link rel="alternate" type="application/rss+xml" title="teyit.org » yorum beslemesi" href="https://web.archive.org/web/20200507111614/https://teyit.org/comments/feed/"/>
<meta name="google-site-verification" content="_It72jV_b1wLMVXw69Wx9CpxhWkNNoanyM-zEsEFqUc"/><link rel="alternate" type="application/rss+xml" title="teyit.org » Covid-19 tedavisinde denenen ilaç ve aşı çalışmaları ne durumda? yorum beslemesi" href="https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/feed/"/>
<script type="application/ld+json">
	{
  "@context": "https://web.archive.org/web/20200507111614/http://schema.org",
  "@type": "ClaimReview",
  "datePublished": "2020-05-05 15:28:06",
  "url": "https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/",
  "itemReviewed":
  {
    "@type": "CreativeWork",
    "author":
    {
      "@type": "Organization",
      "name": "",
	"sameAs": ""
    },
    "datePublished": ""
  },
  "claimReviewed": "",
  "author":
  {
    "@type": "Organization",
    "name": "teyit.org",
    "sameAs": "https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/"
  },
  "reviewRating":
  {
    "@type": "Rating",
    "ratingValue": "-1",
    "bestRating": "-1",
    "worstRating": "-1",
    "alternateName" : "YANLIŞ"
  }
}</script> <script type="text/javascript">
			window._wpemojiSettings = {"baseUrl":"https:\/\/web.archive.org\/web\/20200507111614\/https:\/\/s.w.org\/images\/core\/emoji\/12.0.0-1\/72x72\/","ext":".png","svgUrl":"https:\/\/web.archive.org\/web\/20200507111614\/https:\/\/s.w.org\/images\/core\/emoji\/12.0.0-1\/svg\/","svgExt":".svg","source":{"concatemoji":"https:\/\/web.archive.org\/web\/20200507111614\/https:\/\/teyit.org\/wp-includes\/js\/wp-emoji-release.min.js?ver=5.2.6"}};
			!function(a,b,c){function d(a,b){var c=String.fromCharCode;l.clearRect(0,0,k.width,k.height),l.fillText(c.apply(this,a),0,0);var d=k.toDataURL();l.clearRect(0,0,k.width,k.height),l.fillText(c.apply(this,b),0,0);var e=k.toDataURL();return d===e}function e(a){var b;if(!l||!l.fillText)return!1;switch(l.textBaseline="top",l.font="600 32px Arial",a){case"flag":return!(b=d([55356,56826,55356,56819],[55356,56826,8203,55356,56819]))&&(b=d([55356,57332,56128,56423,56128,56418,56128,56421,56128,56430,56128,56423,56128,56447],[55356,57332,8203,56128,56423,8203,56128,56418,8203,56128,56421,8203,56128,56430,8203,56128,56423,8203,56128,56447]),!b);case"emoji":return b=d([55357,56424,55356,57342,8205,55358,56605,8205,55357,56424,55356,57340],[55357,56424,55356,57342,8203,55358,56605,8203,55357,56424,55356,57340]),!b}return!1}function f(a){var c=b.createElement("script");c.src=a,c.defer=c.type="text/javascript",b.getElementsByTagName("head")[0].appendChild(c)}var g,h,i,j,k=b.createElement("canvas"),l=k.getContext&&k.getContext("2d");for(j=Array("flag","emoji"),c.supports={everything:!0,everythingExceptFlag:!0},i=0;i<j.length;i++)c.supports[j[i]]=e(j[i]),c.supports.everything=c.supports.everything&&c.supports[j[i]],"flag"!==j[i]&&(c.supports.everythingExceptFlag=c.supports.everythingExceptFlag&&c.supports[j[i]]);c.supports.everythingExceptFlag=c.supports.everythingExceptFlag&&!c.supports.flag,c.DOMReady=!1,c.readyCallback=function(){c.DOMReady=!0},c.supports.everything||(h=function(){c.readyCallback()},b.addEventListener?(b.addEventListener("DOMContentLoaded",h,!1),a.addEventListener("load",h,!1)):(a.attachEvent("onload",h),b.attachEvent("onreadystatechange",function(){"complete"===b.readyState&&c.readyCallback()})),g=c.source||{},g.concatemoji?f(g.concatemoji):g.wpemoji&&g.twemoji&&(f(g.twemoji),f(g.wpemoji)))}(window,document,window._wpemojiSettings);
		</script>
<style type="text/css">
img.wp-smiley,
img.emoji {
	display: inline !important;
	border: none !important;
	box-shadow: none !important;
	height: 1em !important;
	width: 1em !important;
	margin: 0 .07em !important;
	vertical-align: -0.1em !important;
	background: none !important;
	padding: 0 !important;
}
</style>
<link rel="stylesheet" id="wp-block-library-css" href="https://web.archive.org/web/20200507111614cs_/https://teyit.org/wp-includes/css/dist/block-library/style.min.css?ver=5.2.6" type="text/css" media="all"/>
<link rel="stylesheet" id="contact-form-7-css" href="https://web.archive.org/web/20200507111614cs_/https://teyit.org/wp-content/plugins/contact-form-7/includes/css/styles.css?ver=5.0.4" type="text/css" media="all"/>
<link rel="stylesheet" id="addthis_all_pages-css" href="https://web.archive.org/web/20200507111614cs_/https://teyit.org/wp-content/plugins/addthis-all/frontend/build/addthis_wordpress_public.min.css?ver=5.2.6" type="text/css" media="all"/>
<link rel="stylesheet" id="cb-main-stylesheet-css" href="https://web.archive.org/web/20200507111614cs_/https://teyit.org/wp-content/themes/15zine/library/css/style.min.css?ver=3.1.2" type="text/css" media="all"/>
<link crossorigin="anonymous" rel="stylesheet" id="cb-font-stylesheet-css" href="//web.archive.org/web/20200507111614cs_/https://fonts.googleapis.com/css?family=Chivo%3A400%2C700%2C900%7COpen+Sans%3A400%2C700%2C400italic&amp;subset=latin%2Clatin-ext&amp;ver=3.1.2" type="text/css" media="all"/>
<!--[if lt IE 10]>
<link rel='stylesheet' id='cb-ie-only-css'  href='https://teyit.org/wp-content/themes/15zine/library/css/ie.css?ver=3.1.2' type='text/css' media='all' />
<![endif]-->
<link rel="stylesheet" id="jetpack_css-css" href="https://web.archive.org/web/20200507111614cs_/https://teyit.org/wp-content/plugins/jetpack/css/jetpack.css?ver=7.3.1" type="text/css" media="all"/>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/themes/15zine/library/js/modernizr.custom.min.js?ver=2.6.2"></script>
<link rel="https://api.w.org/" href="https://teyit.org/wp-json/"/>
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="https://teyit.org/xmlrpc.php?rsd"/>
<link rel="wlwmanifest" type="application/wlwmanifest+xml" href="https://teyit.org/wp-includes/wlwmanifest.xml"/>
<meta name="generator" content="WordPress 5.2.6"/>
<link rel="shortlink" href="https://web.archive.org/web/20200507111614/https://wp.me/p7ZnPD-9uG"/>
<link rel="alternate" type="application/json+oembed" href="https://web.archive.org/web/20200507111614/https://teyit.org/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fteyit.org%2Fcovid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda%2F"/>
<link rel="alternate" type="text/xml+oembed" href="https://web.archive.org/web/20200507111614/https://teyit.org/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fteyit.org%2Fcovid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda%2F&amp;format=xml"/>
<meta property="fb:pages" content="207787009653168"/>


<link rel="dns-prefetch" href="//web.archive.org/web/20200507111614/https://v0.wordpress.com/"/>
<style type="text/css">img#wpstats{display:none}</style><meta name="google-site-verification" content="mBh4rdWMHcefELv_teIbEiHgfdou9XpAPsg-NLGy6wQ"/>
<style type="text/css">.wpcf7-acceptance {
    text-transform: none;
    letter-spacing: 2px;
}
.iddia_box {
    border:4px solid;
    width: calc(100% - 4px);
    background-position: left top;
    background-repeat: no-repeat;
    margin-top: 2em;
}
.destek-kutusu {
     width: 100%;
     border: 13.5px solid #00f9c2;
     padding: 8.5px;
     position: relative;
     margin: 5rem 0;
}
/*teyitpedia4 video fix*/
#post-20636 > footer > div:nth-child(5) ,#post-14799 > footer > div:nth-child(5),#post-12744 > footer > div:nth-child(5),#post-17333 > footer > div:nth-child(5){
    margin-top:170px;
}
.inner-box {
    border: 1px solid #bdccd4;
}
.inner-box p {
    padding: 0 19px;
    padding-top: 28px;
    font-family: 'Chivo', sans-serif;
    font-size: 18px;
}
.badge {
    position: absolute;
    top: 0;
    width: 292px;
    height: auto;
    left: 0;
right: 0;
margin-left: auto;
margin-right: auto;
margin-top: -155px;
}
.right-title {
    float: right;
    width: 150px;
padding-top: 40px;
}
.left-button {
    width: 150px;
    margin-left: 21px;
    margin-top: 40px;
}
.right-button {
    float: right;
    margin: 40px 21px 0 auto;
}
.inner-footer {
    background: #121414;
    color: white;
    padding: 5px 19px;
    font-weight: 800;
    font-size: 16px;
}
.kaynak_box {
    display: none;
}
.cb-module-block .cb-post-title {
    letter-spacing: 0;
    font-weight: 900;
}
.iddia_box.yanlis, .iddia_box.false {
    background-image:url(https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2019/06/yanlis_icon.png);
    border-color: #e43b3b;
}
.yanlis h4, .false h4 {
    color: #e43b3b;
}
.iddia_box.dogru, .iddia_box.true {
    background-image:url(https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2019/06/dogru_icon.png);
    border-color: #3cb64a;
}
.dogru h4, .true h4 {
    color:#3cb64a;
}
.iddia_box.karma, .iddia_box.mixed {
    background-image:url(https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2019/06/karisik_icon.png);
    border-color: #9B28FF;
}
.karma h4, .mixed h4 {
    color:#9B28FF;
}
.iddia_box.belirsiz, .iddia_box.uncertain {
    background-image:url(https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2019/06/supheli_icon.png);
    border-color: #fbd620;
}
.belirsiz h4, .uncertain h4 {
    color: #fbd620;
}
.iddia_text {
    padding: 1em 1em 0 5em;
}
.iddia_title {
    text-align:right;
    width:calc(100% - 1em);
    padding-right:1em;
}
.iddia_title > h4 {
    margin: 0.5em 1em 1em;
}

.cb-fis h1, .cb-post-title, .cb-meta-style-1 .cb-article-meta h2, .cb-meta-style-5 .cb-article-meta h2,.cb-meta-style-2 .cb-article-meta h2 {
    text-transform: none !important;
}
.cb-lks, .cb-comments, .cb-post-meta {
    display: none !important;
}
.cb-module-block .cb-post-title, .cb-meta-style-4 .cb-article-meta h2, #cb-nav-bar {
    text-transform: none !important;
}

#cb-author-box .cb-mask img, .cb-author-details.cb-sidebar .cb-mask img {
    border-radius: 0 !important;
}



.cb-author-details.cb-sidebar .cb-mask img {
    float:left;
}

.cb-author-details.cb-sidebar h3 {
    margin: 0 0 1em 0;
}

.cb-author-details.cb-sidebar .cb-mask {
    padding: 0 0.6em;
}

.cb-author-details .author-link {
    display: block;
    padding-top: 2em;
}

.cb-module-header .cb-module-title {
    margin: 1.2em 0;
}

.cb-meta-style-5 .cb-article-meta {
    padding-bottom: 5px;
}

@media only screen and (min-width: 1200px) {
.cb-meta-style-1 .cb-article-meta h2, .cb-meta-style-5 .cb-article-meta h2 {
    font-size: 24px !important;
}
}

@media only screen and (min-width: 768px) {
.cb-grid-x .cb-grid-feature:hover img {
    opacity: 0.10 !important;
}
}

@media only screen and (min-width: 768px) {
#cb-footer .cb-footer-lower {
    padding-top: 0 !important;
}
    
}

h3.cb-font-header, .cb-sidebar .cb-author-position {
        text-align: left;
    padding-left: 110px;
}

.cb-tm-dark #cb-top-menu,.cb-footer-dark #cb-footer, .cb-footer-dark .cb-footer-lower, .cb-mm-dark #cb-nav-bar .cb-bg {
    background-color: #202020;
}

.no-authorbox #cb-author-box {
    display: none !important;
}

.cb-social-whatsapp {
    background: #25D366;
}

#whatsapp-button {
    display: none;
}

.sayac-widget .single-sayac {
    width: 140px;
    float: left;
    height: 100px;
    background-repeat: no-repeat;
    text-align: right;
    margin-bottom: 20px;
}

.sayac-widget h6 {
    margin: 0 0 4px 0;
    font-weight: 700;
    font-size: 1em;
    text-align: left;
}

.single-sayac span {
    margin-top: 8px;
    display: inline-block;
    margin-right: 10px;
    font-size:2em;
}


.sayac-widget small {
    padding-left: 0.2em;
    font-size: 1em;
}

.single-sayac div {
    background-repeat: no-repeat;
    height:70px;
}

.sayac-widget > a:nth-child(even) {
    margin-left: 1em;
    display: inline-block;
}

.sayac-widget > a {
    
}

.single-sayac .dogru {
        background-image: url(https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/08/yesil_sayac_icon.png);
}

.single-sayac .yanlis {
        background-image: url(https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/08/kirmizi_sayac_icon.png);
}

.single-sayac .karmasik {
        background-image: url(https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/08/mor_sayac_icon.png);
}

.single-sayac .supheli {
        background-image: url(https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/08/sari_sayac_icon.png);
}

.mc_input {
    width: 100%;
    height: 60px;
    border: 0;
    background: #e1e1e1;
    padding: 20px;
    color: #858585;
    -webkit-transition: background .35s;
    -transition: background .35s;
    transition: background .35s;
}

#mc_signup_form .mc_var_label {
    color: #e3e3e3;
}

#mc_signup_submit {
    letter-spacing: 2px;
    text-transform: uppercase;
    margin: 0 0 20px 0;
    display: block;
    font-weight: 700;
    font-size: 12px;
    width: auto;
    padding: 10px 20px;
    margin: 20px 0;
    -webkit-transition: background .35s;
    -transition: background .35s;
    transition: background .35s;
    border: 2px solid #e3e3e3;
    width: inherit;
}

#mc_signup_submit:hover {
    background: #e3e3e3;
}

#mc_signup_form .mc_input {
    margin-top: 10px;
}

.cb-alert {
    font-style: italic;
    text-align: left;
    letter-spacing: inherit;
}

.page-id-749 #cb-top-menu, .single-english #cb-top-menu {
   /* display: none !important; */
}

.single-english .turkish {
    display: none;
}

.single-post .english {
    display: none;
}

.single .cb-byline {
    font-size: 14px;
    margin: 15px 0 15px;
}

.page-id-749 .cb-trending, .page-id-749 .menu-item-946, .single-english .menu-item-946, .single-english .cb-trending, .tax-topics .cb-trending {
    display:none !important;
}

.paged.page-id-749 #cb-section-b, .paged.page-id-749 #cb-section-a {
    display:none !important;
}
#cb-section-a > div {
    margin-bottom: 0px;
}
.page-id-749 #cb-top-menu .cb-search-title, .menu-item-2475 {
    display:none;
}

.elementor-tab-title {
    vertical-align: middle;
    padding: 10px 11px !important;
}

.elementor-tab-title > div {
    width: 80px;
    height: 80px;
    box-shadow: 0px 3px 6px #829BD3;
    background-color: #F7F9FD;
}

.elementor-tab-title > div > img {
    position: relative;
top: 50%;
left: 50%;
transform: translateX(-50%) translateY(-50%);
}

.elementor-tab-title.elementor-active > div {
    background-color: #3996F4;
}

.elementor-tab-title.elementor-active > div:after {
top: 90%;
	left: 50%;
	border: solid transparent;
	content: " ";
	height: 0;
	width: 0;
	position: absolute;
	pointer-events: none;
	border-color: rgba(57, 150, 244, 0);
	border-top-color: #3996F4;
	border-width: 20px;
	margin-left: -20px;
}

.elementor-widget-tabs .elementor-tabs-wrapper {
    overflow: visible !important;
}

.elementor-tab-content {
    box-shadow: rgb(130, 155, 211) 0px 4px 20px;
}

.elementor-tabs-content-wrapper {
    margin-top: 15px;
}

.elementor-tab-content .number {
    float: right;
    font-size: 198px;
    margin-top: -190px;
    display: block;
    line-height: 1;
    color: #E9EDF2;
}

.elementor-tab-content h3:first-of-type {
    padding-top: 30px;
}

.elementor-tab-content p {
    padding-right: 150px;
}

.page-id-5978 #cb-content, .page-id-5978 .cb-post-wrap {
    background: transparent !important;
}

.content-banner-box {
    border: 1px solid black;
    padding: 2rem;
}

.archive.tag .sidebar-kaynak-box, .search .sidebar-kaynak-box {
    display: none;
}

@media only screen and (min-device-width : 320px) and (max-device-width : 480px) {
    #whatsapp-button { display: inline-block; }
    .sayac-widget .single-sayac {
    width: 120px;
    }
}

@media only screen and (max-width: 767px) {

.cb-entry-header {
    padding: 0 10px;
}
.cb-style-1 .cb-meta .cb-post-title {
    font-size: 16px;
}

.sidebar-kaynak-box {
    display: none;
}
.kaynak_box {
    display: block;
}
.inner-box {
    margin-top: 168px;
}
.left-button {
    width: 100px;
}
#cb-section-a > div {
    margin-bottom: 20px;
}
}

@media only screen and (max-width: 1024px) {
    .inner-box {
    margin-top: 168px;
}
#cb-section-a > div {
    margin-bottom: 10px;
}
}
#cb-nav-bar .cb-mega-menu-columns .cb-sub-menu > li > a { color: #ffffff; } .cb-entry-content a {color:#1e73be; } .cb-entry-content a:hover {color:#123e8c; } .cb-entry-content a:active {color:#1e73be; } .cb-entry-content a:visited {color:#dd3333; } .cb-entry-content a:focus {color:#8224e3; }.cb-review-box .cb-bar .cb-overlay span { background: #f9db32; }.cb-review-box i { color: #f9db32; }.cb-meta-style-1 .cb-article-meta { background: rgba(0, 0, 0, 0.25); }@media only screen and (min-width: 768px) {
                .cb-module-block .cb-meta-style-1:hover .cb-article-meta { background: rgba(0, 0, 0, 0.75); }
                .cb-module-block .cb-meta-style-2:hover img, .cb-module-block .cb-meta-style-4:hover img, .cb-grid-x .cb-grid-feature:hover img, .cb-grid-x .cb-grid-feature:hover .cb-fi-cover, .cb-slider li:hover img { opacity: 0.25; }
            }@media only screen and (min-width: 1020px){ body { font-size: 16px; }}.cb-menu-light #cb-nav-bar .cb-main-nav, .cb-stuck.cb-menu-light #cb-nav-bar .cb-nav-bar-wrap { border-bottom-color: #202020; }</style><style type="text/css">body, #respond, .cb-font-body { font-family: 'Open Sans', sans-serif; } h1, h2, h3, h4, h5, h6, .cb-font-header, #bbp-user-navigation, .cb-byline{ font-family:'Chivo', sans-serif; }</style> <meta name="onesignal" content="wordpress-plugin"/>
<link rel="manifest" href="https://web.archive.org/web/20200507111614/https://teyit.org/wp-content/plugins/onesignal-free-web-push-notifications/sdk_files/manifest.json.php?gcm_sender_id="/>
<script src="https://web.archive.org/web/20200507111614js_/https://cdn.onesignal.com/sdks/OneSignalSDK.js" async></script> <script>

      window.OneSignal = window.OneSignal || [];

      OneSignal.push( function() {
        OneSignal.SERVICE_WORKER_UPDATER_PATH = "OneSignalSDKUpdaterWorker.js.php";
        OneSignal.SERVICE_WORKER_PATH = "OneSignalSDKWorker.js.php";
        OneSignal.SERVICE_WORKER_PARAM = { scope: '/' };

        OneSignal.setDefaultNotificationUrl("https://web.archive.org/web/20200507111614/https://teyit.org");
        var oneSignal_options = {};
        window._oneSignalInitOptions = oneSignal_options;

        oneSignal_options['wordpress'] = true;
oneSignal_options['appId'] = 'c110ded6-5817-46f0-a056-8ad4b5cd3489';
oneSignal_options['autoRegister'] = true;
oneSignal_options['httpPermissionRequest'] = { };
oneSignal_options['httpPermissionRequest']['enable'] = true;
oneSignal_options['welcomeNotification'] = { };
oneSignal_options['welcomeNotification']['title'] = "";
oneSignal_options['welcomeNotification']['message'] = "Bildirimleri açtığınız için teşekkürler!";
oneSignal_options['path'] = "https://web.archive.org/web/20200507111614/https://teyit.org/wp-content/plugins/onesignal-free-web-push-notifications/sdk_files/";
oneSignal_options['persistNotification'] = true;
oneSignal_options['promptOptions'] = { };
oneSignal_options['notifyButton'] = { };
oneSignal_options['notifyButton']['enable'] = true;
oneSignal_options['notifyButton']['position'] = 'bottom-right';
oneSignal_options['notifyButton']['theme'] = 'default';
oneSignal_options['notifyButton']['size'] = 'medium';
oneSignal_options['notifyButton']['prenotify'] = true;
oneSignal_options['notifyButton']['showCredit'] = true;
oneSignal_options['notifyButton']['text'] = {};
oneSignal_options['notifyButton']['text']['message.prenotify'] = 'Yeni analizlerde bildirim almak için tıklayın';
oneSignal_options['notifyButton']['text']['tip.state.unsubscribed'] = 'Bildirimleri aç';
oneSignal_options['notifyButton']['text']['tip.state.subscribed'] = 'Bildirimleri açtınız';
oneSignal_options['notifyButton']['text']['tip.state.blocked'] = 'Bildirimleri engellediniz';
oneSignal_options['notifyButton']['text']['message.action.subscribed'] = 'Bildirimleri açtığınız için teşekkürler!';
oneSignal_options['notifyButton']['text']['message.action.resubscribed'] = 'Bildirimlere açtınız';
oneSignal_options['notifyButton']['text']['message.action.unsubscribed'] = 'Bir daha bildirim almayacaksınız';
oneSignal_options['notifyButton']['text']['dialog.main.title'] = 'Bildirim ayarlarını düzenle';
oneSignal_options['notifyButton']['text']['dialog.main.button.subscribe'] = 'BİLDİRİM AL';
oneSignal_options['notifyButton']['text']['dialog.main.button.unsubscribe'] = 'BİLDİRİMLERİ KAPA';
oneSignal_options['notifyButton']['text']['dialog.blocked.title'] = 'Bildirimlerin engelini kaldır';
oneSignal_options['notifyButton']['text']['dialog.blocked.message'] = 'Bildirimleri açmak içi talimatları izleyin:';
              OneSignal.init(window._oneSignalInitOptions);
                    });

      function documentInitOneSignal() {
        var oneSignal_elements = document.getElementsByClassName("OneSignal-prompt");

        var oneSignalLinkClickHandler = function(event) { OneSignal.push(['registerForPushNotifications']); event.preventDefault(); };        for(var i = 0; i < oneSignal_elements.length; i++)
          oneSignal_elements[i].addEventListener('click', oneSignalLinkClickHandler, false);
      }

      if (document.readyState === 'complete') {
           documentInitOneSignal();
      }
      else {
           window.addEventListener("load", function(event){
               documentInitOneSignal();
          });
      }
    </script>
<link rel="amphtml" href="https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/amp/"><style>.cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-11150:hover, .cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-11150:focus { background:# !important ; }
.cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-11150 .cb-big-menu { border-top-color: #; }
.cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-11151:hover, .cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-11151:focus { background:# !important ; }
.cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-11151 .cb-big-menu { border-top-color: #; }
.cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-11152:hover, .cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-11152:focus { background:# !important ; }
.cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-11152 .cb-big-menu { border-top-color: #; }
.cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-4199:hover, .cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-4199:focus { background:# !important ; }
.cb-mm-on #cb-nav-bar .cb-main-nav .menu-item-4199 .cb-big-menu { border-top-color: #; }</style><link rel="icon" href="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2018/11/cropped-teyit_amblem_siyah_72ppi-1-32x32.png" sizes="32x32"/>
<link rel="icon" href="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2018/11/cropped-teyit_amblem_siyah_72ppi-1-192x192.png" sizes="192x192"/>
<link rel="apple-touch-icon-precomposed" href="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2018/11/cropped-teyit_amblem_siyah_72ppi-1-180x180.png"/>
<meta name="msapplication-TileImage" content="https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2018/11/cropped-teyit_amblem_siyah_72ppi-1-270x270.png"/>

</head>
<body class="post-template-default single single-post postid-36498 single-format-standard buyutec dosya saglik  cb-sticky-mm  cb-tm-dark cb-body-light cb-menu-light cb-mm-dark cb-footer-dark   cb-m-logo-off cb-m-sticky cb-sw-tm-fw cb-sw-header-box cb-sw-menu-box cb-sw-footer-fw cb-menu-al-left  cb-fis-b-off  cb-fis-tl-overlay"><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
</style>
<script>__wm.rw(0);</script>
<div id="wm-ipp-base" lang="en" style="display:none;direction:ltr;">
<div id="wm-ipp" style="position:fixed;left:0;top:0;right:0;">
<div id="wm-ipp-inside">
  <div style="position:relative;">
    <div id="wm-logo" style="float:left;width:110px;padding-top:12px;">
      <a href="/web/" title="Wayback Machine home page"><img src="/_static/images/toolbar/wayback-toolbar-logo-200.png" srcset="/_static/images/toolbar/wayback-toolbar-logo-100.png, /_static/images/toolbar/wayback-toolbar-logo-150.png 1.5x, /_static/images/toolbar/wayback-toolbar-logo-200.png 2x" alt="Wayback Machine" style="width:100px" border="0" /></a>
    </div>
    <div class="r" style="float:right;">
      <div id="wm-btns" style="text-align:right;height:25px;">
                  <div id="wm-save-snapshot-success">success</div>
          <div id="wm-save-snapshot-fail">fail</div>
          <a id="wm-save-snapshot-open" href="#"
	     title="Share via My Web Archive" >
            <span class="iconochive-web"></span>
          </a>
          <a href="https://archive.org/account/login.php"
             title="Sign In"
             id="wm-sign-in"
          >
            <span class="iconochive-person"></span>
          </a>
          <span id="wm-save-snapshot-in-progress" class="iconochive-web"></span>
        	<a href="http://faq.web.archive.org/" title="Get some help using the Wayback Machine" style="top:-6px;"><span class="iconochive-question" style="color:rgb(87,186,244);font-size:160%;"></span></a>
	<a id="wm-tb-close" href="#close" onclick="__wm.h(event);return false;" style="top:-2px;" title="Close the toolbar"><span class="iconochive-remove-circle" style="color:#888888;font-size:240%;"></span></a>
      </div>
      <div id="wm-share">
          <a href="/web/20200507111614/http://web.archive.org/screenshot/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/"
             id="wm-screenshot"
             title="screenshot">
            <span class="wm-icon-screen-shot"></span>
          </a>
          <a href="#"
            id="wm-video"
            title="video">
            <span class="iconochive-movies"></span>
          </a>
	<a id="wm-share-facebook" href="#" data-url="https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" title="Share on Facebook" style="margin-right:5px;" target="_blank"><span class="iconochive-facebook" style="color:#3b5998;font-size:160%;"></span></a>
	<a id="wm-share-twitter" href="#" data-url="https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" title="Share on Twitter" style="margin-right:5px;" target="_blank"><span class="iconochive-twitter" style="color:#1dcaff;font-size:160%;"></span></a>
      </div>
    </div>
    <table class="c" style="">
      <tbody>
	<tr>
	  <td class="u" colspan="2">
	    <form target="_top" method="get" action="/web/submit" name="wmtb" id="wmtb"><input type="text" name="url" id="wmtbURL" value="https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" onfocus="this.focus();this.select();" /><input type="hidden" name="type" value="replay" /><input type="hidden" name="date" value="20200507111614" /><input type="submit" value="Go" /></form>
	  </td>
	  <td class="n" rowspan="2" style="width:110px;">
	    <table>
	      <tbody>
		<!-- NEXT/PREV MONTH NAV AND MONTH INDICATOR -->
		<tr class="m">
		  <td class="b" nowrap="nowrap">Apr</td>
		  <td class="c" id="displayMonthEl" title="You are here: 11:16:14 May 07, 2020">MAY</td>
		  <td class="f" nowrap="nowrap"><a href="https://web.archive.org/web/20200915005930/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" title="15 Sep 2020"><strong>Sep</strong></a></td>
		</tr>
		<!-- NEXT/PREV CAPTURE NAV AND DAY OF MONTH INDICATOR -->
		<tr class="d">
		  <td class="b" nowrap="nowrap"><img src="/_static/images/toolbar/wm_tb_prv_off.png" alt="Previous capture" width="14" height="16" border="0" /></td>
		  <td class="c" id="displayDayEl" style="width:34px;font-size:24px;white-space:nowrap;" title="You are here: 11:16:14 May 07, 2020">07</td>
		  <td class="f" nowrap="nowrap"><a href="https://web.archive.org/web/20200513165720/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" title="16:57:20 May 13, 2020"><img src="/_static/images/toolbar/wm_tb_nxt_on.png" alt="Next capture" width="14" height="16" border="0" /></a></td>
		</tr>
		<!-- NEXT/PREV YEAR NAV AND YEAR INDICATOR -->
		<tr class="y">
		  <td class="b" nowrap="nowrap">2019</td>
		  <td class="c" id="displayYearEl" title="You are here: 11:16:14 May 07, 2020">2020</td>
		  <td class="f" nowrap="nowrap">2021</td>
		</tr>
	      </tbody>
	    </table>
	  </td>
	</tr>
	<tr>
	  <td class="s">
	    	    <div id="wm-nav-captures">
	      	      <a class="t" href="/web/20200507111614*/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" title="See a list of every capture for this URL">8 captures</a>
	      <div class="r" title="Timespan for captures of this URL">07 May 2020 - 29 Jan 2021</div>
	      </div>
	  </td>
	  <td class="k">
	    <a href="" id="wm-graph-anchor">
	      <div id="wm-ipp-sparkline" title="Explore captures for this URL" style="position: relative">
		<canvas id="wm-sparkline-canvas" width="650" height="27" border="0"></canvas>
	      </div>
	    </a>
	  </td>
	</tr>
      </tbody>
    </table>
    <div style="position:absolute;bottom:0;right:2px;text-align:right;">
      <a id="wm-expand" class="wm-btn wm-closed" href="#expand" onclick="__wm.ex(event);return false;"><span id="wm-expand-icon" class="iconochive-down-solid"></span> <span style="font-size:80%">About this capture</span></a>
    </div>
  </div>
    <div id="wm-capinfo" style="border-top:1px solid #777;display:none; overflow: hidden">
                    <div id="wm-capinfo-collected-by">
    <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center">COLLECTED BY</div>
    <div style="padding:3px;position:relative" id="wm-collected-by-content">
      <div style="display:inline-block;vertical-align:top;width:49%;">
			<span class="c-logo" style="background-image:url(https://archive.org/services/img/outlinks-from-tweets)"></span>
		<div>Collection: <a style="color:#33f;" href="https://archive.org/details/outlinks-from-tweets" target="_new"><span class="wm-title">Outlinks From Tweets</span></a></div>
	      </div>
    </div>
    </div>
    <div id="wm-capinfo-timestamps">
    <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center" title="Timestamps for the elements of this page">TIMESTAMPS</div>
    <div>
      <div id="wm-capresources" style="margin:0 5px 5px 5px;max-height:250px;overflow-y:scroll !important"></div>
      <div id="wm-capresources-loading" style="text-align:left;margin:0 20px 5px 5px;display:none"><img src="/_static/images/loading.gif" alt="loading" /></div>
    </div>
    </div>
  </div></div></div></div><div id="wm-ipp-print">The Wayback Machine - https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/</div>
<div id="donato" style="position:relative;width:100%;">
  <div id="donato-base">
    <iframe id="donato-if" src="https://archive.org/includes/donate.php?as_page=1&amp;platform=wb&amp;referer=https%3A//web.archive.org/web/20200507111614/https%3A//teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/"
	    scrolling="no" frameborder="0" style="width:100%; height:100%">
    </iframe>
  </div>
</div><script type="text/javascript">
__wm.bt(650,27,25,2,"web","https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/","20200507111614",1996,"/_static/",["/_static/css/banner-styles.css?v=omkqRugM","/_static/css/iconochive.css?v=qtvMKcIJ"], false);
  __wm.rw(1);
</script>
<!-- END WAYBACK TOOLBAR INSERT -->
<div id="cb-outer-container">
<div id="cb-top-menu" class="clearfix cb-font-header ">
<div class="wrap clearfix cb-site-padding cb-top-menu-wrap">
<div class="cb-left-side cb-mob">
<a href="#" id="cb-mob-open" class="cb-link"><i class="fa fa-bars"></i></a>
</div>
<ul class="cb-top-nav cb-left-side"><li id="menu-item-338" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-338"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/nedir/">Nedir?</a></li>
<li id="menu-item-337" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-337"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/yayin-ilkeleri-ve-metodoloji/">Yayın İlkeleri ve Metodoloji</a></li>
<li id="menu-item-336" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-336"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/ekip/">Ekip</a></li>
<li id="menu-item-335" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-335"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/iletisim/">İletişim</a></li>
<li id="menu-item-946" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-946"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/eng/">ENGLISH</a></li>
</ul> <ul class="cb-top-nav cb-right-side"><li class="cb-icon-search cb-menu-icons-extra"><a href="#" title="Arama" id="cb-s-trigger-gen"><i class="fa fa-search"></i> <span class="cb-search-title">Arama</span></a></li><li class="cb-menu-icons-extra cb-social-icons-extra"><a href="https://web.archive.org/web/20200507111614/https://www.twitter.com/teyitorg" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li class="cb-menu-icons-extra cb-social-icons-extra"><a href="https://web.archive.org/web/20200507111614/https://www.facebook.com/teyitorg" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li class="cb-menu-icons-extra cb-social-icons-extra"><a href="https://web.archive.org/web/20200507111614/https://www.linkedin.com/company/teyitorg/" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li class="cb-menu-icons-extra cb-social-icons-extra test"><a href="https://web.archive.org/web/20200507111614/https://eksisozluk.com/biri/teyitorg" target="_blank"><i class="fa fa-tint" aria-hidden="true"></i></a></li><li class="cb-menu-icons-extra cb-social-icons-extra"><a href="https://web.archive.org/web/20200507111614/https://www.instagram.com/teyitorg" target="_blank"><i class="fa fa-instagram" aria-hidden="true"></i></a></li></ul> </div>
</div>
<div id="cb-mob-menu" class="cb-mob-menu">
<div class="cb-mob-close-wrap">
<a href="#" id="cb-mob-close" class="cb-link"><i class="fa cb-times"></i></a>
</div>
<div class="cb-mob-menu-wrap">
<ul id="cb-mob-ul" class="cb-mobile-nav cb-top-nav cb-mob-ul-show"><li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-11150"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/analiz/">Analiz</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category current-post-ancestor current-menu-parent current-post-parent menu-item-11151"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/dosya/">Dosya</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-11152"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/icgoru/">İçgörü</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-4199"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/teyitpedia/">#teyitpedia</a></li>
</ul> </div>
</div>
<div id="cb-container" class="clearfix">
<header id="cb-header" class="cb-header  wrap">
<div id="cb-logo-box" class="cb-logo-left wrap">
<div id="logo">
<a href="https://web.archive.org/web/20200507111614/https://teyit.org/">
<img src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/header-logo_72ppi.png" alt="teyit.org logo" data-at2x="https://web.archive.org/web/20200507111614/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/header-logo-retina_72ppi.png">
</a>
</div>
</div>
</header>
<div id="cb-menu-search" class="cb-s-modal cb-modal"><div class="cb-close-m cb-ta-right"><i class="fa cb-times"></i></div><div class="cb-s-modal-inner cb-pre-load cb-light-loader cb-modal-inner cb-font-header cb-mega-three cb-mega-posts clearfix"><form method="get" class="cb-search" action="https://web.archive.org/web/20200507111614/https://teyit.org/">
<input type="text" class="cb-search-field cb-font-header" placeholder="Arama.." value="" name="s" title="" autocomplete="off">
<button class="cb-search-submit" type="submit" value=""><i class="fa fa-search"></i></button>
</form><div id="cb-s-results"></div></div></div>
<nav id="cb-nav-bar" class="clearfix  wrap">
<div class="cb-nav-bar-wrap cb-site-padding clearfix cb-font-header  wrap">
<ul class="cb-main-nav wrap clearfix"><li id="menu-item-11150" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-11150"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/analiz/">Analiz</a></li>
<li id="menu-item-11151" class="menu-item menu-item-type-taxonomy menu-item-object-category current-post-ancestor current-menu-parent current-post-parent menu-item-11151"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/dosya/">Dosya</a></li>
<li id="menu-item-11152" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-11152"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/icgoru/">İçgörü</a></li>
<li id="menu-item-4199" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-4199"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/teyitpedia/">#teyitpedia</a></li>
<li id="menu-item-trending" class="cb-trending"><a href="#" id="cb-trend-menu-item" class="cb-trending-item"><i class="fa fa-bolt"></i> POPÜLER</a><div class="cb-menu-drop cb-mega-menu  cb-bg cb-big-menu"><div id="cb-trending-block" class="cb-mega-trending cb-mega-posts cb-pre-load clearfix"><div class="cb-upper-title"><h2><i class="fa fa-bolt"></i> POPÜLER</h2><span class="cb-see-all"><a href="#" data-cb-r="cb-1" class="cb-selected cb-trending-op">Şu an</a><a href="#" data-cb-r="cb-2" class="cb-trending-op">Geçen hafta</a><a href="#" data-cb-r="cb-3" class="cb-trending-op">Geçen ay</a></span></div><ul id="cb-trend-data" class="clearfix"> <li class="cb-article-1 clearfix"><div class="cb-mask"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/deniz-gezmisin-asilmasi-icin-144-chpli-vekilden-97sinin-evet-oyu-kullandigi-iddiasi/"><img width="360" height="240" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2017/08/deniz-gezmisin-asilmasi-icin-144-chpli-vekilden-97sinin-evet-oyu-kullandigi-iddiasi-360x240.jpg" class="attachment-cb-360-240 size-cb-360-240 wp-post-image" alt=""/></a></div><div class="cb-meta"><span class="cb-post-views"><i class="fa fa-bolt"></i> 20258</span><h2 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/deniz-gezmisin-asilmasi-icin-144-chpli-vekilden-97sinin-evet-oyu-kullandigi-iddiasi/">Deniz Gezmiş’in asılması için 144 CHP’li vekilden 97’sinin “Evet” oyu kullandığı iddiası</a></h2></div><span class="cb-countdown">1</span><a href="https://web.archive.org/web/20200507111614/https://teyit.org/deniz-gezmisin-asilmasi-icin-144-chpli-vekilden-97sinin-evet-oyu-kullandigi-iddiasi/" class="cb-link-overlay"></a></li> <li class="cb-article-2 clearfix"><div class="cb-mask"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/a-haber-ekraninda-yarim-dolar-352-lira-yazdigi-iddiasi/"><img width="360" height="240" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/httpsteyit.orga-haber-ekraninda-yarim-dolar-3-52-lira-yazdigi-iddiasi-360x240.jpg" class="attachment-cb-360-240 size-cb-360-240 wp-post-image" alt=""/></a></div><div class="cb-meta"><span class="cb-post-views"><i class="fa fa-bolt"></i> 5591</span><h2 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/a-haber-ekraninda-yarim-dolar-352-lira-yazdigi-iddiasi/">A Haber ekranında yarım dolar 3,52 lira yazdığı iddiası</a></h2></div><span class="cb-countdown">2</span><a href="https://web.archive.org/web/20200507111614/https://teyit.org/a-haber-ekraninda-yarim-dolar-352-lira-yazdigi-iddiasi/" class="cb-link-overlay"></a></li> <li class="cb-article-3 clearfix"><div class="cb-mask"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/kira-odenmediginde-sozlesmenin-feshedilemeyecegi-iddiasi/"><img width="360" height="240" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/Kira-ödenmediğinde-sözleşmenin-feshedilemeyeceği-iddiası-1-360x240.png" class="attachment-cb-360-240 size-cb-360-240 wp-post-image" alt=""/></a></div><div class="cb-meta"><span class="cb-post-views"><i class="fa fa-bolt"></i> 2612</span><h2 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/kira-odenmediginde-sozlesmenin-feshedilemeyecegi-iddiasi/">Kira ödenmediğinde sözleşmenin feshedilemeyeceği iddiası</a></h2></div><span class="cb-countdown">3</span><a href="https://web.archive.org/web/20200507111614/https://teyit.org/kira-odenmediginde-sozlesmenin-feshedilemeyecegi-iddiasi/" class="cb-link-overlay"></a></li></ul></div></div></li></ul> </div>
</nav>
<div id="cb-content" class="wrap clearfix">
<div class="cb-entire-post cb-first-alp clearfix">
<div class="cb-post-wrap cb-wrap-pad wrap clearfix cb-sidebar-right">
<meta itemprop="datePublished" content="2020-05-05T15:28:06+03:00">
<meta itemprop="dateModified" content="2020-05-06T11:06:43+03:00">
<meta itemscope itemprop="mainEntityOfPage" itemtype="https://schema.org/WebPage" itemid="https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/">
<span class="cb-hide" itemscope itemprop="publisher" itemtype="https://schema.org/Organization">
<meta itemprop="name" content="teyit.org">
<meta itemprop="url" content="https://web.archive.org/web/20200507111614/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/header-logo_72ppi.png">
<span class="cb-hide" itemscope itemprop="logo" itemtype="https://schema.org/ImageObject">
<meta itemprop="url" content="https://web.archive.org/web/20200507111614/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/header-logo_72ppi.png">
</span>
</span>
<meta itemprop="headline " content="Covid-19 tedavisinde denenen ilaç ve aşı çalışmaları ne durumda?">
<span class="cb-hide" itemscope itemtype="http://schema.org/ImageObject" itemprop="image">
<meta itemprop="url" content="https://web.archive.org/web/20200507111614/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/Covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda.png">
<meta itemprop="width" content="750">
<meta itemprop="height" content="350">
</span>
<div class="cb-main clearfix">
<article id="post-36498" class="clearfix post-36498 post type-post status-publish format-standard has-post-thumbnail hentry category-buyutec category-dosya category-saglik tag-asi tag-covid-19 tag-ilac tag-koronavirus">
<div class="cb-entry-header cb-meta clearfix"><h1 class="entry-title cb-entry-title cb-title">Covid-19 tedavisinde denenen ilaç ve aşı çalışmaları ne durumda?</h1><div class="cb-byline"><span class="cb-author"> <a href="https://web.archive.org/web/20200507111614/https://teyit.org/author/ezgi/">Ezgi Toprak</a></span><span class="cb-separator"><i class="fa fa-times"></i></span><span class="cb-date test"><time datetime="2020-05-05">05/05/2020<span class="cb-separator"><i class="fa fa-times"></i></span>15:28</time></span></div><div class="cb-post-meta"><span class="cb-category cb-element"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/dosya/buyutec/" title="Büyüteç tarafından eklenmiş tüm yazılar">Büyüteç</a></span><span class="cb-category cb-element"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/dosya/" title="Dosya tarafından eklenmiş tüm yazılar">Dosya</a></span><span class="cb-category cb-element"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/konu/saglik/" title="Sağlık tarafından eklenmiş tüm yazılar">Sağlık</a></span><span class="cb-comments cb-element"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/#respond">Yorum yok</a></span></div></div>
<section class="cb-entry-content clearfix" itemprop="articleBody">
<div class="at-above-post addthis_tool" data-url="https://web.archive.org/web/20200507111614oe_/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/"></div><span class="cb-itemprop" itemprop="reviewBody"><p><span style="font-weight: 400">Covid-19, Aralık ayından beri hayatımızda. Salgının gündelik yaşamımızdaki derin etkilerinin ortadan kalkması, yani olağan yaşantımıza dönebilmek ise sosyal mesafeyi koruyabilmek ve bulaşı önleyecek önlemlere dikkat etmeye devam etmekten geçiyor. Ancak tüm dünyanın merakla beklediği ve umut bağladığı bir mesele daha var: Salgını durdurabilecek yani virüsü yenebilecek bir aşı ya da ilacın geliştirilebilmesi.&nbsp;</span></p>
<p><span style="font-weight: 400">Hastalığın tedavisinde etkili olabileceği düşüncesiyle kullanılan bazı ilaçlar olduğu biliniyor. Bu ilaçların tamamı, daha önce başka hastalıkların tedavisinde kullanılıyordu; klinik araştırmalarda Covid-19 üzerinde de etkili oldukları görüldü. Tabii bir de aşı çalışmalarına bakmak gerek. Pek çok ülkede eşzamanlı olarak birçok çalışması devam ediyor. Fakat aşı, geçtiği aşamalar nedeniyle en az bir yıl daha hayatımızda olamayacak gibi öngörülüyor.&nbsp;</span></p>
<p><span style="font-weight: 400">Yani halen Covid-19’u tedavi edebilecek kesinleşmiş bir ilaç ya da önleyebilecek bir aşı yok. Dünya Sağlık Örgütü tedavinin bulunmasında daha hızlı çalışılabilmesi için uluslararası işbirliğiyle “Dayanışma” başlıklı klinik deneme çalışması </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/6ujvc"><span style="font-weight: 400">başlattı</span></a><span style="font-weight: 400">.&nbsp;</span></p>
<p><span style="font-weight: 400">Peki, tüm bu ilaç ve aşılar, nasıl bir yol izleyerek kullanabilir hale geliyor? İlaç ve aşıların güncel durumları ne? Öncelikle ilaç ve aşı çalışma süreçlerinde </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/WeVOU"><span style="font-weight: 400">ABD</span></a><span style="font-weight: 400">’de ve </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/FLJqr"><span style="font-weight: 400">Avrupa</span></a><span style="font-weight: 400">’da </span><a href="https://web.archive.org/web/20200507111614/https://www.ema.europa.eu/en/documents/presentation/presentation-how-are-medicines-evaluated-ema-nathalie-bere_en.pdf"><span style="font-weight: 400">benzer</span></a><span style="font-weight: 400"> yollar </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/BQJvu"><span style="font-weight: 400">izleniyor</span></a><span style="font-weight: 400">. Bu durum Türkiye’de yapılan aşı ve ilaç çalışmaları için de </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/079r9"><span style="font-weight: 400">geçerli.</span></a><span style="font-weight: 400">&nbsp;</span></p>
<h3><b>İlaç çalışmalarının süreci ve Covid-19 tedavisinde denenen ilaçlar</b></h3>
<p><span style="font-weight: 400">Covid-19’un tedavisi için denenen ilaçlar genel hatlarıyla birkaç şekilde </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/oLobZVy"><span style="font-weight: 400">kategorilendirilebilir.</span></a><span style="font-weight: 400"> Bunlardan biri virüsün vücutta gelişme yeteneğini doğrudan etkileyebilecek antiviral ilaçlar. Bir diğeri, bağışıklık sistemine etki edebilecek ilaçlar ve antimalaryal </span><i><span style="font-weight: 400">(sıtma tedavisinde kullanılan)</span></i><span style="font-weight: 400"> ilaçlar. Bu ilaçların geçtiği aşamalar ise bir ilacın yeniden keşfedilmesi gibi baştan başlayan bir süreci içermese de yine de kolay görünmüyor.&nbsp;</span></p>
<p><span style="font-weight: 400">İlaç araştırmalarına, </span><b>keşif ve geliştirme</b><span style="font-weight: 400"> aşamasıyla </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/0Uex7"><span style="font-weight: 400">başlanıyor.</span></a><span style="font-weight: 400"> Fakat Covid-19 tedavisi için denenen tüm ilaçlar zaten belirli hastalıklar için kullanılan ilaçlar. Bu nedenle ikinci aşama olan klinik öncesi araştırmaya bakarak başlayalım.&nbsp;</span></p>
<p><b>Adım 2: </b><span style="font-weight: 400">Klinik öncesi araştırma fazı&nbsp;</span></p>
<p><span style="font-weight: 400">Bu aşamada araştırmacılar ilacı insanlarda test etmeden önce toksisite olarak da adlandırılan ilacın ciddi zarar verme potansiyeline sahip olup olmadığını </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/f6WQx"><span style="font-weight: 400">öğreniyor.</span></a><span style="font-weight: 400"> Klinik öncesi araştırmanın, iki türü bulunuyor. Bunlardan ilki </span><b><i>in vitro</i></b><span style="font-weight: 400"> testler, canlı organizma yerine, kontrollü bir çevrede yani laboratuvar ortamında test tüpü ya da cam kaplarda gerçekleştirilen deneyler. Bir diğeri ise </span><b><i>in vivo</i></b><b>, </b><span style="font-weight: 400">yani canlı organizmayı kullanarak yapılan deneyleri tanımlıyor. Klinik öncesi testlerden sonra araştırmacılar bulgularını gözden geçirip ilacın insanlarda test edilip edilmeyeceğine karar veriyor. Bu adımda hayvanlar üzerinde yapılan deneylerin de sonuçları </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/079r9"><span style="font-weight: 400">alınıyor.</span></a><span style="font-weight: 400">&nbsp;</span></p>
<p><b>Adım 3</b><span style="font-weight: 400">: Klinik araştırma fazı</span></p>
<p><span style="font-weight: 400">Klinik öncesi araştırmanın tamamlanmasıyla ilaçların, güvenli ve etkili olduklarından emin olmak için insanlar üzerinde test edildiği aşama olan klinik araştırmaya </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/hskVA"><span style="font-weight: 400">geçiliyor.</span></a><span style="font-weight: 400"> Bu aşamada araştırmacılar, ilaçla ilgili belirli araştırma sorularını cevaplamak için klinik araştırmalar tasarlıyor. Bu soruların arasında ilacın denenmesinde kimlerin katılımcı olacağı, çalışmaya katılacak kişi sayısı, çalışmanın ne kadar süreceği, ilacın hastalara hangi dozda verileceği gibi temel soruların cevaplanması bekleniyor. Bu soruların cevapları doğrultusunda üçüncü adımda çalışmanın fazlarını göreceğimiz bir alt başlık açmamız gerekiyor. Bu başlıklarda çalışmaya katılan kişi sayısını, çalışma süresini ve amacı ayrıntılı şekilde görüyoruz.&nbsp;</span></p>
<table>
<tbody>
<tr>
<td></td>
<td><b>Çalışma Katılımcıları</b></td>
<td><b>Çalışma Süresi</b></td>
<td><b>Amaç&nbsp;</b></td>
</tr>
<tr>
<td><b>Faz I&nbsp;</b></td>
<td><span style="font-weight: 400">20 ila 100 sağlıklı gönüllü veya hastalığı / rahatsızlığı olan kişiler</span></td>
<td><span style="font-weight: 400">Birkaç ay</span></td>
<td><span style="font-weight: 400">İlacın güvenli olup olmadığı ve kullanılacak dozajın belirlenmesi</span></td>
</tr>
<tr>
<td><b>Faz II</b></td>
<td><span style="font-weight: 400">Hastalığı / rahatsızlığı olan yüzlerce kişiye kadar</span></td>
<td><span style="font-weight: 400">Birkaç aydan 2 yıla kadar</span></td>
<td><span style="font-weight: 400">İlacın olası olumlu-olumsuz etkilerinin belirlenmesi</span></td>
</tr>
<tr>
<td><b>Faz III</b></td>
<td><span style="font-weight: 400">Hastalığı veya rahatsızlığı olan 300 ila 3 bin gönüllü</span></td>
<td><span style="font-weight: 400">1 ila 4 yıl</span></td>
<td><span style="font-weight: 400">Önceki çalışmalarda daha az yaygın yan etkilerin tespit edilmemiş olması ihtimaline karşı olumsuz reaksiyonların izlenmesi&nbsp;</span></td>
</tr>
<tr>
<td><b>Faz IV</b></td>
<td><span style="font-weight: 400">Hastalığı / rahatsızlığı olan binlerce gönüllü</span></td>
<td></td>
<td><span style="font-weight: 400">İlacın piyasaya sürüldükten sonra güvenliğini ve etkinliğini izlemek&nbsp;</span></td>
</tr>
</tbody>
</table>
<p><i style="font-size: inherit">Klinik araştırma aşamasında izlenen alt fazlar (Normal şartlarda)</i></p>
<p><span style="font-weight: 400">Tüm bu fazların çalışma süresi sıfırdan hayatımıza giren bir ilacın sürelerini gösteriyor. Covid-19 tedavisinde denenen ilaçların çok daha hızlı denendiğini ve sonuç alındığını görüyoruz, çünkü ‘normal’ bir süreçten geçmiyoruz.&nbsp;</span></p>
<p><span style="font-weight: 400">Gelelim Covid-19 tedavisinde denenen ilaçların ne durumda oldukları kısmına. Denendiği bilinen 245 tedavi araştırması </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/RnNEf"><span style="font-weight: 400">var</span></a><span style="font-weight: 400">. Bunların büyük bir bölümü ise ilaçlar. Bu ilaçlardan biri de ikincil enfeksiyonları önlemek için kullanılan bir antibiyotik.&nbsp;</span></p>
<table>
<tbody>
<tr>
<td><b>İlaç / Etken Madde</b></td>
<td><b>Faz I</b></td>
<td><b>Faz II</b></td>
<td><b>Faz III</b></td>
<td><b>Faz IV</b></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://archive.is/C0NWq"><span style="font-weight: 400">Remdesivir</span></a><span style="font-weight: 400">*</span></p>
<p><span style="font-weight: 400">(Antiviral ilaç)</span></td>
<td></td>
<td></td>
<td><span style="font-weight: 400">x</span></td>
<td></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://archive.is/kF6BV"><span style="font-weight: 400">Hidroksiklorokin</span></a></p>
<p><span style="font-weight: 400">(Sıtma ilacı)</span></td>
<td></td>
<td></td>
<td><span style="font-weight: 400">x</span></td>
<td></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/dMONoAe"><span style="font-weight: 400">Klorokin</span></a></p>
<p><span style="font-weight: 400">(Sıtma ilacı)</span></td>
<td></td>
<td></td>
<td><span style="font-weight: 400">x</span></td>
<td></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/weFcYpR"><span style="font-weight: 400">Favipiravir</span></a></p>
<p><span style="font-weight: 400">(Antiviral ilaç)</span></td>
<td></td>
<td><span style="font-weight: 400">x</span></td>
<td></td>
<td></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/qkcpaOO"><span style="font-weight: 400">Tocilizumab</span> </a></p>
<p><span style="font-weight: 400">(İltihaplı eklem romatizması ilacı)</span></td>
<td></td>
<td></td>
<td><span style="font-weight: 400">x</span></td>
<td></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/qyIdDbn"><span style="font-weight: 400">Lopinavir + Ritonavir kombinasyonu</span></a></p>
<p><span style="font-weight: 400">(HIV ilacı)</span></td>
<td></td>
<td><span style="font-weight: 400">x</span></td>
<td></td>
<td></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/WNKYRKN"><span style="font-weight: 400">Oseltamivir</span></a></p>
<p><span style="font-weight: 400">(Antiviral ilaç)</span></td>
<td></td>
<td></td>
<td><span style="font-weight: 400">x</span></td>
<td></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/eRaDBqA"><span style="font-weight: 400">Azitromisin</span></a></p>
<p><span style="font-weight: 400">(Antibiyotik)</span></td>
<td></td>
<td><span style="font-weight: 400">x</span></td>
<td></td>
<td></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/zYZXzKK"><span style="font-weight: 400">Sarilumab</span></a></p>
<p><span style="font-weight: 400">(İltihaplı eklem romatizması ilacı)</span></td>
<td></td>
<td><span style="font-weight: 400">x</span></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<p><i><span style="font-weight: 400">*Remdesivirin faz 3 aşaması sonuçları açıklandı ve FDA ilaç için acil kullanım izni </span></i><a href="https://web.archive.org/web/20200507111614/https://archive.is/6r182"><i><span style="font-weight: 400">verdi.</span></i></a><i><span style="font-weight: 400"> Ancak henüz Covid-19 tedavisi için kullanımı onaylanmadı.&nbsp;</span></i></p>
<p><span style="font-weight: 400">Tabloda yer alan ilaçlardan bazıları Dünya Sağlık Örgütü’nün klinik deneme çalışmaları içinde yer </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/6ujvc"><span style="font-weight: 400">alıyor</span></a><span style="font-weight: 400">. Bu ilaçlar dışında denenen onlarca ilaç daha var, ancak henüz tablodakiler dışında aralarından sıyrılan biri </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/q0xiy"><span style="font-weight: 400">bulunmuyor</span></a><span style="font-weight: 400">. Özetleyecek olursak ilaç çalışmaları olabildiğince hızlı ilerliyor. Bu hız nedeniyle ilacın denendiği kişi sayısı ve çalışma süreleri farklılaşıyor. Ancak amaçları aynı.&nbsp;</span></p>
<h3><b>Aşı çalışmalarının süreci ve Covid-19 tedavisi için denemeler</b></h3>
<p><span style="font-weight: 400">Aşı çalışmaları da tıpkı ilaç çalışmaları gibi hızlı ilerliyor görünüyor. Ancak virüsü önleyebilecek bir aşının hayatlarımıza girebilmesi için uzun bir yolculuğu tamamlaması gerekiyor. Çünkü aşı, zaten hastalanmış insanlara değil, hastalıkla karşılaşmamış, belki de hiç karşılaşmayacak insanlara da, yani çok geniş popülasyonlara uygulanıyor ve risklerin çok daha dikkatli hesap edilmesi gerekiyor. Yine de hemen her gün bu konuda yeni adımlar atıldığı hatta bu adımların umut vaat edebileceği de konuşuluyor. Peki normal şartlarda bir aşının bulunması için hangi aşamalardan geçmesi gerekiyor, bu kadar hızlı aşı üretilebilir mi ve Covid-19’u yenebilecek aşı çalışmaları ne durumda?&nbsp;</span></p>
<p><b>Adım 1</b><span style="font-weight: 400">: Keşif ve formül geliştirme fazı</span></p>
<p><span style="font-weight: 400">İlk adım olan keşif aşaması temel laboratuvar araştırmalarını </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/JgFjYKb"><span style="font-weight: 400">içeriyor.</span></a><span style="font-weight: 400"> Bu aşamanın normal şartlarda yaklaşık iki ila dört yıl sürmesi bekleniyor. Bilim insanlarının yapacağı keşifle bir hastalığı önlemeye veya tedavi etmeye yardımcı olabilecek doğal veya sentetik antijenleri tanımlaması gerekiyor. Bu antijenler virüs benzeri parçacıklar, zayıflamış virüsler veya bakteriler, zayıflamış bakteriyel toksinleri veya patojenlerden türetilen diğer maddeleri içerebiliyor.&nbsp;</span></p>
<p><b>Adım 2</b><span style="font-weight: 400">: Klinik öncesi araştırma fazı</span></p>
<p><span style="font-weight: 400">Klinik öncesi çalışmalar, aday aşının güvenliğini ve bağışıklık tepkisi verip vermeyeceğinin değerlendirilmesini </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/acMKyrj"><span style="font-weight: 400">içeriyor</span></a><span style="font-weight: 400">. Bu değerlendirmeler, laboratuvar deneyleri ya da hayvan deneklerden elde edilen bilgilerle yapılabiliyor. Ortaya çıkacak sonuçlar insanlarda yaşanabilecek olası hücresel tepkiler hakkında fikir veriyor. Ayrıca araştırmanın bir sonraki aşamaya geçmesi için aday aşının güvenilir başlangıç dozu ve uygulanışına ilişkin bilgiler elde ediliyor. Fakat birçok aday aşının bu aşamadan öteye geçemediği ve gereken bağışıklık tepkisini alamadığı biliniyor. Klinik öncesi çalışmalar bir iki yıl sürüyor. Bu çalışmaların devamında ABD’de Gıda ve İlaç İdaresi&#8217;ne bir yeni ilaç (IND) başvurusu yapılması gerekiyor. Avrupa’da ise ilaç değerlendirmeleri için Avrupa İlaç Ajansı (EMA)’na </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/ti48g"><span style="font-weight: 400">başvuruluyor.</span></a><span style="font-weight: 400">&nbsp;</span></p>
<p><b>Adım 3</b><span style="font-weight: 400">: Klinik araştırma fazı</span></p>
<p><span style="font-weight: 400">Normalde araştırmacıların, bilim insanlarının aday aşı için fon sağlamak, onay almak ve sonuçları parça parça incelemek için yıllara ihtiyaçları var. Ancak içinde bulunduğumuz dönem aday aşı geliştirilebilmesi için de ‘normal’ işlemiyor. En az bir iki yıl sürmesi beklenen klinik öncesi çalışmalar, bir ay içinde tamamlanabiliyor. Üçüncü adımda bulunan klinik gelişmelere de hızla geçilmiş oluyor. Bu aşamada faz deneyleri başlıyor.&nbsp;</span></p>
<table>
<tbody>
<tr>
<td></td>
<td><b>Çalışma Katılımcıları</b></td>
<td><b>Amaç</b></td>
</tr>
<tr>
<td><b>Faz I</b></td>
<td><span style="font-weight: 400">Yetişkin 20 ila 80 kişi (denek)&nbsp;</span></td>
<td><span style="font-weight: 400">Aday aşının güvenliğini değerlendirmek ve aşının neden olduğu bağışıklık tepkisinin tipini ve kapsamını belirlemek</span></td>
</tr>
<tr>
<td><b>Faz II</b></td>
<td><span style="font-weight: 400">Yetişkin birkaç yüz kişi&nbsp;</span></td>
<td><span style="font-weight: 400">Aday aşının güvenliğini, immünojenisitesini, önerilen dozları, aşılama programını ve uygulama yöntemini incelemek</span></td>
</tr>
<tr>
<td><b>Faz III</b></td>
<td><span style="font-weight: 400">Binlerce, hatta 10 binlerce kişi</span></td>
<td><span style="font-weight: 400">Bazı nadir yan etkilerin önceki evrelerdeki küçük denek gruplarında ortaya çıkmama ihtimalini değerlendirmek</span></td>
</tr>
</tbody>
</table>
<p><i><span style="font-weight: 400">Klinik Araştırma aşamasında izlenen fazlar (Normal şartlarda)</span></i></p>
<p><b>Adım 4:</b><span style="font-weight: 400"> Aşıların Lisans Sonrası İzlenmesi</span></p>
<p><span style="font-weight: 400">Bu aşama aşı konusunda izlenecek gerekli yasal prosedürleri içeriyor. Faz III aşamasının başarıyla tamamlanması aşının lisanslanmaya ve kullanıma hazır olduğu anlamına geliyor. Kullanıma başlandıktan sonra ise faz IV aşaması uygulanabiliyor. Faz IV’ün uygulanmasındaki amaç, nadir görülen olumsuz etkileri tespit etmek ve aşının uzun vadeli etkinliğini ve potansiyelini değerlendirmeyi amaçlamak.</span></p>
<p><span style="font-weight: 400">Bugün aşina olduğumuz tüm aşılar, aynı aşamalardan geçerek uygulanabilir hale geldiler. Ancak Covid-19 salgını farklı bir süreç ve birkaç ayda klinik araştırma kısmına geçildiği görülüyor. Bunun en önemli sebeplerinden biri, koronavirüs ailesinden tanınan SARS ve MERS gibi hastalıklarla ilgili daha önce </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/RmzLGNU"><span style="font-weight: 400">çalışmalar</span></a><span style="font-weight: 400">. 30 Nisan 2020 itibariyle üzerinde çalışılan 102 aday aşı olduğu </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/VOHCwSP"><span style="font-weight: 400">biliniyor.</span></a><span style="font-weight: 400"> Bu aşılardan sekizi klinik araştırma aşamasında.</span></p>
<table>
<tbody>
<tr>
<td><b>Aday Aşı&nbsp;</b></td>
<td><b>Çalışan Ülke ve Kurum&nbsp;</b></td>
<td><b>Faz</b></td>
<td><b>Çalışmanın Tahmini Bitiş Tarihi</b></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://archive.is/z9MvB"><span style="font-weight: 400">ChAdOx1 </span></a><a href="https://web.archive.org/web/20200507111614/https://teyit.link/JNMSvvQ"><span style="font-weight: 400">nCoV-19</span></a></td>
<td><span style="font-weight: 400">İngiltere &#8211; Oxford Üniversitesi&nbsp;</span></td>
<td><span style="font-weight: 400">I-II</span></td>
<td><span style="font-weight: 400">Mayıs 2021</span></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/ZVlEbTc"><span style="font-weight: 400">CTII-nCoV</span></a></td>
<td><span style="font-weight: 400">Çin &#8211; Biyoteknoloji Enstitüsü, Askeri Tıp Bilimleri Akademisi ve CanSino Biologics işbirliği</span></td>
<td><span style="font-weight: 400">I-II</span></td>
<td><span style="font-weight: 400">31 Ocak 2021</span></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/uZDGxko"><span style="font-weight: 400">INO-4800</span></a></td>
<td><span style="font-weight: 400">ABD &#8211; Inovio Pharmaceuticals</span></td>
<td><span style="font-weight: 400">I</span></td>
<td><span style="font-weight: 400">Nisan 2021</span></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://archive.is/pREci"><span style="font-weight: 400">ChiCTR2000031809</span></a></td>
<td><span style="font-weight: 400">Çin &#8211; Wuhan Biyolojik Ürünler Enstitüsü ve Sinopharm</span></td>
<td><span style="font-weight: 400">I</span></td>
<td><span style="font-weight: 400">Kasım 2021</span></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/yoitwMr"><span style="font-weight: 400">Covid-19-Sinovac</span></a></td>
<td><span style="font-weight: 400">Çin &#8211; Sinovac Biyoteknoloji</span></td>
<td><span style="font-weight: 400">I-II</span></td>
<td><span style="font-weight: 400">13 Aralık 2020</span></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://archive.is/iHuU4"><span style="font-weight: 400">BNT162-01</span></a></td>
<td><span style="font-weight: 400">Almanya-Çin-ABD BioNTech/Fosun Pharma/Pfizer</span></td>
<td><span style="font-weight: 400">I-II</span></td>
<td><span style="font-weight: 400">&#8211;</span></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://teyit.link/chXrlwi"><span style="font-weight: 400">2019-nCoV Vaccine</span></a></td>
<td><span style="font-weight: 400">ABD &#8211; Kaiser Permanente Washington Sağlık Araştırma Enstitüsü, Ulusal Alerji ve Bulaşıcı Hastalıklar Enstitüsü ve Moderna</span></td>
<td><span style="font-weight: 400">I</span></td>
<td><span style="font-weight: 400">1 Haziran 2021</span></td>
</tr>
<tr>
<td><a href="https://web.archive.org/web/20200507111614/https://archive.is/18c1t"><span style="font-weight: 400">NVX-CoV2373</span></a></td>
<td><span style="font-weight: 400">ABD &#8211; Novavax ve Nucleus</span></td>
<td><span style="font-weight: 400">Mayıs ayı içinde faz I’in başlaması bekleniyor</span></td>
<td><span style="font-weight: 400">&#8211;</span></td>
</tr>
</tbody>
</table>
<p><span style="font-weight: 400">Tabloya bakıldığında aday aşıların klinik aşama çalışmalarına geçtiği görülse de, çalışmaların tahmini bitişleri, en erken 2021 yılına tarihleniyor. Oxford Üniversitesi’nin aşıyı yıl sonuna hazırlayabilecekleri </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/CUarv"><span style="font-weight: 400">açıklamaları</span></a><span style="font-weight: 400"> olsa da bu tahminin toplumdaki bulaş durumuna bağlı olarak gelişeceğini belirtiyorlar. Bulaş yüksek olursa aday aşının işe yarayıp yaramadığını görmek için birkaç ay içinde yeterli veri alınabileceği ancak bu seviye düşerse, sürenin 6 aya kadar çıkabileceği söyleniyor. Ayrıca ABD Ulusal Alerji ve Enfeksiyon Hastalıkları Enstitüsü Müdürü Dr. Anthony Fauci de önümüzdeki kışa aşının hazır olabileceği konusunda iyimser olduğunu </span><a href="https://web.archive.org/web/20200507111614/https://archive.is/mYRin"><span style="font-weight: 400">söylemişti.</span></a><span style="font-weight: 400">&nbsp;</span></p>
<h3><b>Türkiye aşı ve ilaç denemelerinde nerede?</b></h3>
<p><span style="font-weight: 400">ABD ve Avrupa’da aşı çalışmalarının hız kesmeden devam ettiği ve birçok ilacı da klinik aşamalarda hızla kullandıkları görülüyor. Türkiye de çalışmaları olan ülkelerden biri. <a href="https://web.archive.org/web/20200507111614/https://archive.is/a0GZt">TÜBİTAK</a> bu konuda önemli bazı çalışmalar yürütüyor. 25&#8217;i üniversite toplam 41 kuruluş &#8216;Covid-19 Türkiye Platformu&#8217; çatısı altında ilaç ve aşı çalışmalarını </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/dcojAWU"><span style="font-weight: 400">sürdürüyor.</span></a><span style="font-weight: 400"> Projelerden dokuzu ilaç çalışmasıyken sekizi de aşı çalışmasından oluşuyor. Aşı çalışmalarından biri, ODTÜ, Hacettepe ve Bilkent Üniversitesi işbirliğinde </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/xtqYKqj"><span style="font-weight: 400">gelişiyor.</span></a><span style="font-weight: 400"> Çalışmalar, Bilkent Üniversitesi Moleküler Biyoloji ve Genetik Bölümü Öğretim Üyesi ve TÜBİTAK Covid-19 Konsorsiyumu üyesi Prof. Dr. İhsan Gürsel ve ODTÜ Biyolojik Bilimler Bölümü Öğretim Üyesi Prof. Dr. Mayda Gürsel önderliğinde </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/gMFVMqE"><span style="font-weight: 400">yürütülüyor.</span></a><span style="font-weight: 400"> Bu çalışmaların ise henüz keşif ve geliştirme aşamasında olduğu, ancak kısa bir süre içinde hayvan deneylerine geçilebileceği söyleniyor. Dokuz ayın sonunda ise insan çalışmalarına başlanması planlanıyor.</span></p>
<p><span style="font-weight: 400">Bir başka çalışma Acıbadem Labcell Hücre Laboratuvarı ve Kordon Kanı Bankası Direktörü Prof. Dr. Ercüment Ovalı ve ekibine ait. Ovalı, Covid-19’a karşı bir ilacın klinik öncesi araştırmasını yapacaklarını duyurmuş ve nisan ayında o ilacın virüsü öldürmede etkili olduğunu </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/nfqtQvY"><span style="font-weight: 400">açıklamıştı.</span></a><span style="font-weight: 400"> Aynı ekibin, iki farklı aşı çalışmasının laboratuvar kısmını yani klinik öncesi araştırma kısmını tamamladıklarını hayvan deneylerine geçtiği </span><a href="https://web.archive.org/web/20200507111614/https://teyit.link/LJFJWnW"><span style="font-weight: 400">biliniyor</span></a><span style="font-weight: 400">.</span></p>
<p><span style="font-weight: 400">Bu gelişmelerin dışında Türkiye’de hastaların tedavisinde denenen ilaçlar da hazırladığımız tablodakilerle neredeyse aynı. Sağlık Bakanlığı’nın Covid-19 tedavisinde kullanılan ilaçları ve bu ilaçların etkileşimlerini görebildiğimiz bir raporu da </span><a href="https://web.archive.org/web/20200507111614/https://dosyamerkez.saglik.gov.tr/Eklenti/37078,covid--19-tedavisinde-kullanilan-ilaclar---ilac-etkilesimleripdf.pdf?0"><span style="font-weight: 400">bulunuyor.</span></a><span style="font-weight: 400">&nbsp;</span></p>
<p><span style="font-weight: 400">Sonuç olarak Covid-19 tedavisinde denenen birçok ilaç ve aşı çalışması var. İlaç çalışmalarında öne çıkanlardan biri Remdesivir olarak görülüyor. Aşı çalışmalarında ise Oxford Üniversitesi’nin hızlı davrandığı söylenebilir. Ancak tüm bunların sonuçları ancak aylar sonra alınabilecek.&nbsp;</span></p>
<div class="kaynak_box"><h3><b>Kaynaklar</b></h3>
<p><span style="font-weight: 400">BBC News, </span><a href="https://web.archive.org/web/20200507111614/https://www.bbc.com/news/health-52354520"><span style="font-weight: 400">Coronavirus cure: When will we have a drug to treat it?</span></a><span style="font-weight: 400">, 30 Nisan 2020</span></p>
<p><span style="font-weight: 400">BBC Türkçe, </span><a href="https://web.archive.org/web/20200507111614/https://www.bbc.com/turkce/haberler-turkiye-52330826"><span style="font-weight: 400">Dornaz Alfa: Prof. Dr. Ercüment Ovalı’nın 'Covid-19 ilacı' açıklamasıyla başlayan tartışmada kim, ne dedi?</span></a><span style="font-weight: 400">, 17 Nisan 2020</span></p>
<p><span style="font-weight: 400">BioWorld, </span><a href="https://web.archive.org/web/20200507111614/https://www.bioworld.com/COVID19products"><span style="font-weight: 400">Biopharma products in development for COVID-19</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://www.clinicaltrialsarena.com/news/french-early-trial-tocilizumab-covid-19/"><span style="font-weight: 400">Genentech’s arthritis drug tocilizumab shows promise in Covid-19 trial</span></a><span style="font-weight: 400">, 29 Nisan 2020</span></p>
<p><span style="font-weight: 400">Chinese Clinical Trial Registry, </span><a href="https://web.archive.org/web/20200507111614/http://www.chictr.org.cn/showprojen.aspx?proj=52227"><span style="font-weight: 400">A randomized, double-blind, placebo parallel-controlled phase I/II clinical trial for inactivated Novel Coronavirus Pneumonia vaccine</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/NCT04327388"><span style="font-weight: 400">Sarilumab COVID-19</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/NCT04324606"><span style="font-weight: 400">A Study of a Candidate COVID-19 Vaccine (COV001)</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/NCT04341389"><span style="font-weight: 400">A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 </span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/NCT04336410?term=inovio&amp;cond=covid-19&amp;draw=2&amp;rank=1"><span style="font-weight: 400">Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/record/NCT04352608"><span style="font-weight: 400">Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB00608"><span style="font-weight: 400">Chloroquine</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB12466"><span style="font-weight: 400">Favipiravir</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB01601"><span style="font-weight: 400">Lopinavir</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB00198"><span style="font-weight: 400">Oseltamivir</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB00207"><span style="font-weight: 400">Azithromycin</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/covid-19"><span style="font-weight: 400">COVID-19 Information</span></a></p>
<p><span style="font-weight: 400">EU Clinical Trials Register, </span><a href="https://web.archive.org/web/20200507111614/https://www.clinicaltrialsregister.eu/ctr-search/search?query=BNT162-01"><span style="font-weight: 400">Clinical trials for BNT162-01</span></a></p>
<p><span style="font-weight: 400">EU Vaccine, </span><a href="https://web.archive.org/web/20200507111614/http://www.euvaccine.eu/vaccines-diseases/vaccines/stages-development"><span style="font-weight: 400">Stages of vaccine development</span></a></p>
<p><span style="font-weight: 400">European Medicines Agency, </span><a href="https://web.archive.org/web/20200507111614/https://www.ema.europa.eu/en/documents/presentation/presentation-how-are-medicines-evaluated-ema-nathalie-bere_en.pdf"><span style="font-weight: 400">Overview of medicines development</span></a></p>
<p><span style="font-weight: 400">European Medicines Agency, </span><a href="https://web.archive.org/web/20200507111614/https://www.ema.europa.eu/en/news/how-are-new-medicines-approved-ema"><span style="font-weight: 400">How are new medicines approved by EMA?</span></a></p>
<p><span style="font-weight: 400">Euronews, </span><a href="https://web.archive.org/web/20200507111614/https://tr.euronews.com/2020/04/23/turk-bilim-insan-ndan-covid-19-as-mujdesi-2-farkl-as-uretiminde-sira-hayvan-deneylerinde"><span style="font-weight: 400">Türk bilim insanından Covid-19 aşı müjdesi: 2 farklı aşı üretiminde sıra hayvan deneylerinde</span></a><span style="font-weight: 400">, 23 Nisan 2020</span></p>
<p>Evrensel, <a href="https://web.archive.org/web/20200507111614/https://www.evrensel.net/haber/402627/prof-dr-ihsan-gursel-virusun-gen-haritasi-asi-calismalarinda-yol-gosterecek">Prof. Dr. İhsan Gürsel: Virüsün gen haritası aşı çalışmalarında yol gösterecek</a>, 20 Nisan 2020</p>
<p><span style="font-weight: 400">FDA, </span><a href="https://web.archive.org/web/20200507111614/https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process"><span style="font-weight: 400">The Drug Development Process</span></a></p>
<p><span style="font-weight: 400">FDA, </span><a href="https://web.archive.org/web/20200507111614/https://www.fda.gov/patients/drug-development-process/step-1-discovery-and-development"><span style="font-weight: 400">Step 1: Discovery and Development</span></a></p>
<p><span style="font-weight: 400">FDA, </span><a href="https://web.archive.org/web/20200507111614/https://www.fda.gov/patients/drug-development-process/step-2-preclinical-research"><span style="font-weight: 400">Step 2: Preclinical Research</span></a></p>
<p><span style="font-weight: 400">FDA, </span><a href="https://web.archive.org/web/20200507111614/https://www.fda.gov/patients/drug-development-process/step-3-clinical-research"><span style="font-weight: 400">Step 3: Clinical Research</span></a></p>
<p>Gazete Duvar, <a href="https://web.archive.org/web/20200507111614/https://www.gazeteduvar.com.tr/bilim/2020/04/08/odtu-bilkent-ve-hacettepeden-ortak-asi-calismasi/">ODTÜ, Bilkent ve Hacettepe'den ortak aşı çalışması</a>, 8 Nisan 2020</p>
<p><span style="font-weight: 400">Gilead, </span><a href="https://web.archive.org/web/20200507111614/https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19"><span style="font-weight: 400">Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19</span></a><span style="font-weight: 400">, 29 Nisan 2020</span></p>
<p><span style="font-weight: 400">NIH, </span><a href="https://web.archive.org/web/20200507111614/https://www.niaid.nih.gov/diseases-conditions/covid-19"><span style="font-weight: 400">COVID-19, Mers &amp; Sars</span></a></p>
<p><span style="font-weight: 400">Novavax, </span><a href="https://web.archive.org/web/20200507111614/https://ir.novavax.com/news-releases/news-release-details/novavax-identifies-coronavirus-vaccine-candidate-accelerates"><span style="font-weight: 400">Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May</span></a><span style="font-weight: 400">, 8 Nisan 2020</span></p>
<p><span style="font-weight: 400">Pfizer, </span><a href="https://web.archive.org/web/20200507111614/https://www.pfizer.com.tr/arge/yeni-ila%C3%A7-geli%C5%9Ftirme-s%C3%BCreci"><span style="font-weight: 400">Yeni İlaç Geliştirme Süreci</span></a></p>
<p><span style="font-weight: 400">Sağlık Bakanlığı, </span><a href="https://web.archive.org/web/20200507111614/https://dosyamerkez.saglik.gov.tr/Eklenti/37078,covid--19-tedavisinde-kullanilan-ilaclar---ilac-etkilesimleripdf.pdf?0"><span style="font-weight: 400">COVID-19 Tedavisinde Kullanılan İlaçlar ve İlaç Etkileşimleri</span></a><span style="font-weight: 400">, 3 Nisan 2020</span></p>
<p>Sputnik, <a href="https://web.archive.org/web/20200507111614/https://tr.sputniknews.com/turkiye/202004251041905889-tubitak-koronavirus-asisi-ve-ilaci-icin-tarih-verdi/">TÜBİTAK, koronavirüs aşısı ve ilacı için tarih verdi</a>, 25 Nisan 2020</p>
<p><span style="font-weight: 400">The Hill, </span><a href="https://web.archive.org/web/20200507111614/https://thehill.com/policy/healthcare/495412-fauci-hundreds-of-millions-of-coronavirus-vaccine-doses-may-be-ready-by"><span style="font-weight: 400">Fauci: Hundreds of millions of coronavirus vaccine doses may be ready by January</span></a><span style="font-weight: 400">, 30 Nisan 2020</span></p>
<p><span style="font-weight: 400">The History Vaccine, </span><a href="https://web.archive.org/web/20200507111614/https://www.historyofvaccines.org/content/articles/vaccine-development-testing-and-regulation"><span style="font-weight: 400">Vaccine Development, Testing, and Regulation</span></a></p>
<p><span style="font-weight: 400">The New York Times,  </span><a href="https://web.archive.org/web/20200507111614/https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html"><span style="font-weight: 400">In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead</span></a><span style="font-weight: 400">, 27 Nisan 2020</span></p>
<p><span style="font-weight: 400">The Washington Post, </span><a href="https://web.archive.org/web/20200507111614/https://www.washingtonpost.com/world/2020/05/01/coronavirus-latest-news/?utm_campaign=wp_main&amp;utm_medium=social&amp;utm_source=twitter#link-FZ4IZN4JFFERLKPAYD26WUFEH4"><span style="font-weight: 400">FDA grants emergency authorization to drug for coronavirus; White House blocks Fauci from testifying before House subcommittee</span></a><span style="font-weight: 400">, 2 Mayıs 2020</span></p>
<p>TÜBİTAK, <a href="https://web.archive.org/web/20200507111614/https://covid19.tubitak.gov.tr/">Covid-19 Türkiye Portalı</a></p>
<p><span style="font-weight: 400">University of Oxford, </span><a href="https://web.archive.org/web/20200507111614/http://www.ox.ac.uk/news/2020-04-23-oxford-covid-19-vaccine-begins-human-trial-stage"><span style="font-weight: 400">Oxford COVID-19 vaccine begins human trial stage</span></a><span style="font-weight: 400">, 23 Nisan 2020</span></p>
<p><span style="font-weight: 400">Vaccines Europe, </span><a href="https://web.archive.org/web/20200507111614/https://www.vaccineseurope.eu/about-vaccines/how-are-vaccines-developed"><span style="font-weight: 400">How are vaccines developed?</span></a></p>
<p><span style="font-weight: 400">WHO, </span><a href="https://web.archive.org/web/20200507111614/https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines"><span style="font-weight: 400">Draft landscape of COVID 19 candidate vaccines</span></a><span style="font-weight: 400">, 30 Nisan 2020</span></p>
<p><span style="font-weight: 400">WHO, </span><a href="https://web.archive.org/web/20200507111614/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments"><span style="font-weight: 400">“Solidarity” clinical trial for COVID-19 treatments</span></a></p>
<p><strong><em>Kapak Görseli:</em></strong> Laura Kammermann</p>
</div></span><div class="at-below-post addthis_tool" data-url="https://web.archive.org/web/20200507111614oe_/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/"></div><div class="at-below-post-recommended addthis_tool"></div>
</section> 
<footer class="cb-article-footer">
<p class="cb-tags cb-post-footer-block"> <a href="https://web.archive.org/web/20200507111614/https://teyit.org/etiket/asi/" rel="tag">Aşı</a><a href="https://web.archive.org/web/20200507111614/https://teyit.org/etiket/covid-19/" rel="tag">Covid-19</a><a href="https://web.archive.org/web/20200507111614/https://teyit.org/etiket/ilac/" rel="tag">ilaç</a><a href="https://web.archive.org/web/20200507111614/https://teyit.org/etiket/koronavirus/" rel="tag">Koronavirüs</a></p><div class="cb-social-sharing cb-color-buttons cb-post-footer-block cb-on-color clearfix"><div class="cb-color-sharing-buttons"><a href="https://web.archive.org/web/20200507111614/https://www.facebook.com/sharer/sharer.php?u=https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" target="_blank" class="cb-social-fb cb-tip-bot" data-cb-tip="Paylaş"><i class="fa fa-facebook" aria-hidden="true"></i></a><a href="https://web.archive.org/web/20200507111614/https://twitter.com/share?url=https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" target="_blank" class="cb-social-tw cb-tip-bot" data-cb-tip="Tweetle"><i class="fa fa-twitter" aria-hidden="true"></i></a><a href="https://web.archive.org/web/20200507111614/whatsapp://send/?text=Covid-19+tedavisinde+denenen+ila%C3%A7+ve+a%C5%9F%C4%B1+%C3%A7al%C4%B1%C5%9Fmalar%C4%B1+ne+durumda%3F https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" data-action="share/whatsapp/share" class="cb-social-whatsapp cb-tip-bot" id="whatsapp-button"><i class="fa fa-whatsapp" aria-hidden="true"></i></a><a href="https://web.archive.org/web/20200507111614/https://plus.google.com/share?url=https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/" target="_blank" class="cb-social-go cb-tip-bot" data-cb-tip="Paylaş"><i class="fa fa-google-plus" aria-hidden="true"></i></a><a href="/web/20200507111614/https://teyit.org/cdn-cgi/l/email-protection#ab94c9c4cfd296c3dfdfdbd8918484dfced2c2df85c4d9cc84c8c4ddc2cf869a9286dfcecfcaddc2d8c2c5cfce86cfcec5cec5cec586c2c7cac886ddce86cad8c286c8cac7c2d8c6cac7cad9c286c5ce86cfded9dec6cfca84" class="cb-social-em cb-tip-bot" data-cb-tip="E-posta"><i class="fa fa-envelope" aria-hidden="true"></i></a></div></div><div class="cb-post-large cb-post-footer-block clearfix"></div><div class="destek-kutusu"><img class="badge" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/badges_dosya.png"/><div class="inner-box"><a href="https://web.archive.org/web/20200507111614/http://destek.teyit.org/" target="_blank"><img class="left-button" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/button_dosya.png"/></a><a href="https://web.archive.org/web/20200507111614/http://destek.teyit.org/" target="_blank"><img class="right-button" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/patreon72_25.png"/></a><p><span style="font-weight: 400">Şüpheli bilgilerden yola çıkarak veriye dayalı ve uzun soluklu bir araştırma neticesinde hazırladığımız Dosya yazısını sonuna kadar okuduğunuz için teşekkürler. </span></p>
<p><span style="font-weight: 400">Bu kategorideki yazılarımızı daha hızlı sürede hazırlamamız ve daha fazla kişiye ulaştırabilmemiz için bizi <strong>Patreon</strong> sayfamızdan destekleyebilirsiniz.  </span></p>
<div class="inner-footer">DESTEĞİNİZİN ARDINDAN ADINIZIN YAZDIĞI DOSYA ROZETİ, DİJİTAL VE BASKIYA HAZIR HALDE E-POSTA ADRESİNİZE GÖNDERİLECEKTİR.</div></div></div><div id="cb-author-box" class="cb-post-footer-block cb-post-block-bg clearfix"><div class="cb-mask"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/author/ezgi/"><img src="https://web.archive.org/web/20200507111614im_/https://teyit.org/wp-content/authors/ezgi-87.png" class="avatar photo" alt="Ezgi Toprak" width="96" height="96"/></a></div><div class="cb-meta"><div class="cb-title cb-font-header vcard"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/author/ezgi/"><span class="fn">Ezgi Toprak</span></a></div><div class="cb-author-position cb-font-header">Yazar</div><p class="cb-author-bio">Anadolu Üniversitesi İletişim Bilimleri Fakültesi Basın ve Yayın bölümü mezunu. Aynı üniversitenin Basın ve Yayın Anabilim dalında yüksek lisansına devam ediyor. Milliyet gazetesi ve CNN Türk'te stajyerlik yaptı. Bir yapım şirketinde editör olarak çalıştı. Siyasal iletişim ve yeni medya konularıyla ilgileniyor.</p></div></div><div id="cb-related-posts-block" class="cb-post-footer-block cb-arrows-tr cb-module-block clearfix"><h3 class="cb-title cb-title-header">Alakalı analizler</h3><ul class="slides clearfix"> <li class="cb-style-1 clearfix cb-no-1 post-36663 post type-post status-publish format-standard has-post-thumbnail hentry category-teyitpedia tag-koronavirus tag-yanlis-bilgi">
<div class="cb-mask"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/koronavirus-yanlis-bilgi-ureten-ve-yayan-yedi-insan-tipi/"><img width="360" height="240" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/yanlis-bilgi-ureten-ve-yayan-yedi-insan-tipi-360x240.png" class="attachment-cb-360-240 size-cb-360-240 wp-post-image" alt=""/></a></div>
<div class="cb-meta">
<h4 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/koronavirus-yanlis-bilgi-ureten-ve-yayan-yedi-insan-tipi/">Koronavirüs: Yanlış bilgi üreten ve yayan yedi insan tipi</a></h4>
<div class="cb-byline"><span class="cb-date test"><time datetime="2020-05-07">07/05/2020<span class="cb-separator"><i class="fa fa-times"></i></span>13:00</time></span></div> </div>
</li>
<li class="cb-style-1 clearfix cb-no-2 post-36627 post type-post status-publish format-standard has-post-thumbnail hentry category-analiz category-kriz category-saglik category-yanlis tag-bulas tag-klima tag-koronavirus">
<div class="cb-mask"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/klima-kullaniminin-yeni-koronavirusun-yayilimini-artirdigi-icin-yasaklanabilecegi-iddiasi/"><img width="360" height="240" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/klima-kullaniminin-yeni-koronavirusun-yayilimini-artirdigi-icin-yasaklanabilecegi-iddiasi-360x240.png" class="attachment-cb-360-240 size-cb-360-240 wp-post-image" alt=""/></a></div>
<div class="cb-meta">
<h4 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/klima-kullaniminin-yeni-koronavirusun-yayilimini-artirdigi-icin-yasaklanabilecegi-iddiasi/">Klima kullanımının yeni koronavirüsün yayılımını artırdığı için yasaklanabileceği iddiası</a></h4>
<div class="cb-byline"><span class="cb-author"> <a href="https://web.archive.org/web/20200507111614/https://teyit.org/author/oykum/">Öyküm Hüma Keskin</a></span><span class="cb-separator"><i class="fa fa-times"></i></span><span class="cb-date test"><time datetime="2020-05-06">06/05/2020<span class="cb-separator"><i class="fa fa-times"></i></span>20:48</time></span></div> </div>
</li>
</ul></div>
<div id="comments" class="cb-post-footer-block clearfix">
<div id="respond" class="comment-respond">
<h3 id="reply-title" class="comment-reply-title">Yorum yap <small><a rel="nofollow" id="cancel-comment-reply-link" href="/web/20200507111614/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/#respond" style="display:none;">Cevabı iptal et</a></small></h3> <form action="https://web.archive.org/web/20200507111614/https://teyit.org/wp-comments-post.php" method="post" id="commentform" class="comment-form">
<p class="comment-notes">Email adresiniz yayınlanmayacak.</p><p class="comment-form-comment"><label for="comment">Yorum</label><textarea id="comment" name="comment" cols="45" rows="8" aria-required="true"></textarea></p><p class="comment-form-author"><label for="author">İsminiz<span class="required">*</span></label> <input id="author" name="author" type="text" value="" size="30" aria-required="true"/></p>
<p class="comment-form-email"><label for="email">E-posta<span class="required">*</span></label> <input id="email" name="email" type="text" value="" size="30" aria-required="true"/></p>
<p class="comment-form-url"><label for="url">Website</label><input id="url" name="url" type="text" value="" size="30"/></p>
<p class="comment-form-cookies-consent"><input id="wp-comment-cookies-consent" name="wp-comment-cookies-consent" type="checkbox" value="yes"/><label for="wp-comment-cookies-consent">Bir dahaki sefere yorum yaptığımda kullanılmak üzere adımı, e-posta adresimi ve web site adresimi bu tarayıcıya kaydet.</label></p>
<p class="form-submit"><input name="submit" type="submit" id="submit" class="submit" value="Yorum yap"/> <input type="hidden" name="comment_post_ID" value="36498" id="comment_post_ID"/>
<input type="hidden" name="comment_parent" id="comment_parent" value="0"/>
</p><p class="comment-subscription-form"><input type="checkbox" name="subscribe_comments" id="subscribe_comments" value="subscribe" style="width: auto; -moz-appearance: checkbox; -webkit-appearance: checkbox;"/> <label class="subscribe-label" id="subscribe-label" for="subscribe_comments">Beni sonraki yorumlar için e-posta ile bilgilendir.</label></p><p class="comment-subscription-form"><input type="checkbox" name="subscribe_blog" id="subscribe_blog" value="subscribe" style="width: auto; -moz-appearance: checkbox; -webkit-appearance: checkbox;"/> <label class="subscribe-label" id="subscribe-blog-label" for="subscribe_blog">Beni yeni yazılarda e-posta ile bilgilendir.</label></p><p style="display: none;"><input type="hidden" id="akismet_comment_nonce" name="akismet_comment_nonce" value="99c84bd895"/></p><p style="display: none;"><input type="hidden" id="ak_js" name="ak_js" value="234"/></p> </form>
</div>
</div>
</footer> 
</article> 
</div> 
<div class="sidebar-kaynak-box cb-sidebar clearfix cb-entry-content"><h3><b>Kaynaklar</b></h3>
<p><span style="font-weight: 400">BBC News, </span><a href="https://web.archive.org/web/20200507111614/https://www.bbc.com/news/health-52354520"><span style="font-weight: 400">Coronavirus cure: When will we have a drug to treat it?</span></a><span style="font-weight: 400">, 30 Nisan 2020</span></p>
<p><span style="font-weight: 400">BBC Türkçe, </span><a href="https://web.archive.org/web/20200507111614/https://www.bbc.com/turkce/haberler-turkiye-52330826"><span style="font-weight: 400">Dornaz Alfa: Prof. Dr. Ercüment Ovalı’nın 'Covid-19 ilacı' açıklamasıyla başlayan tartışmada kim, ne dedi?</span></a><span style="font-weight: 400">, 17 Nisan 2020</span></p>
<p><span style="font-weight: 400">BioWorld, </span><a href="https://web.archive.org/web/20200507111614/https://www.bioworld.com/COVID19products"><span style="font-weight: 400">Biopharma products in development for COVID-19</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://www.clinicaltrialsarena.com/news/french-early-trial-tocilizumab-covid-19/"><span style="font-weight: 400">Genentech’s arthritis drug tocilizumab shows promise in Covid-19 trial</span></a><span style="font-weight: 400">, 29 Nisan 2020</span></p>
<p><span style="font-weight: 400">Chinese Clinical Trial Registry, </span><a href="https://web.archive.org/web/20200507111614/http://www.chictr.org.cn/showprojen.aspx?proj=52227"><span style="font-weight: 400">A randomized, double-blind, placebo parallel-controlled phase I/II clinical trial for inactivated Novel Coronavirus Pneumonia vaccine</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/NCT04327388"><span style="font-weight: 400">Sarilumab COVID-19</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/NCT04324606"><span style="font-weight: 400">A Study of a Candidate COVID-19 Vaccine (COV001)</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/NCT04341389"><span style="font-weight: 400">A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 </span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/NCT04336410?term=inovio&amp;cond=covid-19&amp;draw=2&amp;rank=1"><span style="font-weight: 400">Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers</span></a></p>
<p><span style="font-weight: 400">Clinical Trials, </span><a href="https://web.archive.org/web/20200507111614/https://clinicaltrials.gov/ct2/show/record/NCT04352608"><span style="font-weight: 400">Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB00608"><span style="font-weight: 400">Chloroquine</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB12466"><span style="font-weight: 400">Favipiravir</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB01601"><span style="font-weight: 400">Lopinavir</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB00198"><span style="font-weight: 400">Oseltamivir</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/drugs/DB00207"><span style="font-weight: 400">Azithromycin</span></a></p>
<p><span style="font-weight: 400">Drugbank, </span><a href="https://web.archive.org/web/20200507111614/https://www.drugbank.ca/covid-19"><span style="font-weight: 400">COVID-19 Information</span></a></p>
<p><span style="font-weight: 400">EU Clinical Trials Register, </span><a href="https://web.archive.org/web/20200507111614/https://www.clinicaltrialsregister.eu/ctr-search/search?query=BNT162-01"><span style="font-weight: 400">Clinical trials for BNT162-01</span></a></p>
<p><span style="font-weight: 400">EU Vaccine, </span><a href="https://web.archive.org/web/20200507111614/http://www.euvaccine.eu/vaccines-diseases/vaccines/stages-development"><span style="font-weight: 400">Stages of vaccine development</span></a></p>
<p><span style="font-weight: 400">European Medicines Agency, </span><a href="https://web.archive.org/web/20200507111614/https://www.ema.europa.eu/en/documents/presentation/presentation-how-are-medicines-evaluated-ema-nathalie-bere_en.pdf"><span style="font-weight: 400">Overview of medicines development</span></a></p>
<p><span style="font-weight: 400">European Medicines Agency, </span><a href="https://web.archive.org/web/20200507111614/https://www.ema.europa.eu/en/news/how-are-new-medicines-approved-ema"><span style="font-weight: 400">How are new medicines approved by EMA?</span></a></p>
<p><span style="font-weight: 400">Euronews, </span><a href="https://web.archive.org/web/20200507111614/https://tr.euronews.com/2020/04/23/turk-bilim-insan-ndan-covid-19-as-mujdesi-2-farkl-as-uretiminde-sira-hayvan-deneylerinde"><span style="font-weight: 400">Türk bilim insanından Covid-19 aşı müjdesi: 2 farklı aşı üretiminde sıra hayvan deneylerinde</span></a><span style="font-weight: 400">, 23 Nisan 2020</span></p>
<p>Evrensel, <a href="https://web.archive.org/web/20200507111614/https://www.evrensel.net/haber/402627/prof-dr-ihsan-gursel-virusun-gen-haritasi-asi-calismalarinda-yol-gosterecek">Prof. Dr. İhsan Gürsel: Virüsün gen haritası aşı çalışmalarında yol gösterecek</a>, 20 Nisan 2020</p>
<p><span style="font-weight: 400">FDA, </span><a href="https://web.archive.org/web/20200507111614/https://www.fda.gov/patients/learn-about-drug-and-device-approvals/drug-development-process"><span style="font-weight: 400">The Drug Development Process</span></a></p>
<p><span style="font-weight: 400">FDA, </span><a href="https://web.archive.org/web/20200507111614/https://www.fda.gov/patients/drug-development-process/step-1-discovery-and-development"><span style="font-weight: 400">Step 1: Discovery and Development</span></a></p>
<p><span style="font-weight: 400">FDA, </span><a href="https://web.archive.org/web/20200507111614/https://www.fda.gov/patients/drug-development-process/step-2-preclinical-research"><span style="font-weight: 400">Step 2: Preclinical Research</span></a></p>
<p><span style="font-weight: 400">FDA, </span><a href="https://web.archive.org/web/20200507111614/https://www.fda.gov/patients/drug-development-process/step-3-clinical-research"><span style="font-weight: 400">Step 3: Clinical Research</span></a></p>
<p>Gazete Duvar, <a href="https://web.archive.org/web/20200507111614/https://www.gazeteduvar.com.tr/bilim/2020/04/08/odtu-bilkent-ve-hacettepeden-ortak-asi-calismasi/">ODTÜ, Bilkent ve Hacettepe'den ortak aşı çalışması</a>, 8 Nisan 2020</p>
<p><span style="font-weight: 400">Gilead, </span><a href="https://web.archive.org/web/20200507111614/https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19"><span style="font-weight: 400">Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19</span></a><span style="font-weight: 400">, 29 Nisan 2020</span></p>
<p><span style="font-weight: 400">NIH, </span><a href="https://web.archive.org/web/20200507111614/https://www.niaid.nih.gov/diseases-conditions/covid-19"><span style="font-weight: 400">COVID-19, Mers &amp; Sars</span></a></p>
<p><span style="font-weight: 400">Novavax, </span><a href="https://web.archive.org/web/20200507111614/https://ir.novavax.com/news-releases/news-release-details/novavax-identifies-coronavirus-vaccine-candidate-accelerates"><span style="font-weight: 400">Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May</span></a><span style="font-weight: 400">, 8 Nisan 2020</span></p>
<p><span style="font-weight: 400">Pfizer, </span><a href="https://web.archive.org/web/20200507111614/https://www.pfizer.com.tr/arge/yeni-ila%C3%A7-geli%C5%9Ftirme-s%C3%BCreci"><span style="font-weight: 400">Yeni İlaç Geliştirme Süreci</span></a></p>
<p><span style="font-weight: 400">Sağlık Bakanlığı, </span><a href="https://web.archive.org/web/20200507111614/https://dosyamerkez.saglik.gov.tr/Eklenti/37078,covid--19-tedavisinde-kullanilan-ilaclar---ilac-etkilesimleripdf.pdf?0"><span style="font-weight: 400">COVID-19 Tedavisinde Kullanılan İlaçlar ve İlaç Etkileşimleri</span></a><span style="font-weight: 400">, 3 Nisan 2020</span></p>
<p>Sputnik, <a href="https://web.archive.org/web/20200507111614/https://tr.sputniknews.com/turkiye/202004251041905889-tubitak-koronavirus-asisi-ve-ilaci-icin-tarih-verdi/">TÜBİTAK, koronavirüs aşısı ve ilacı için tarih verdi</a>, 25 Nisan 2020</p>
<p><span style="font-weight: 400">The Hill, </span><a href="https://web.archive.org/web/20200507111614/https://thehill.com/policy/healthcare/495412-fauci-hundreds-of-millions-of-coronavirus-vaccine-doses-may-be-ready-by"><span style="font-weight: 400">Fauci: Hundreds of millions of coronavirus vaccine doses may be ready by January</span></a><span style="font-weight: 400">, 30 Nisan 2020</span></p>
<p><span style="font-weight: 400">The History Vaccine, </span><a href="https://web.archive.org/web/20200507111614/https://www.historyofvaccines.org/content/articles/vaccine-development-testing-and-regulation"><span style="font-weight: 400">Vaccine Development, Testing, and Regulation</span></a></p>
<p><span style="font-weight: 400">The New York Times,  </span><a href="https://web.archive.org/web/20200507111614/https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html"><span style="font-weight: 400">In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead</span></a><span style="font-weight: 400">, 27 Nisan 2020</span></p>
<p><span style="font-weight: 400">The Washington Post, </span><a href="https://web.archive.org/web/20200507111614/https://www.washingtonpost.com/world/2020/05/01/coronavirus-latest-news/?utm_campaign=wp_main&amp;utm_medium=social&amp;utm_source=twitter#link-FZ4IZN4JFFERLKPAYD26WUFEH4"><span style="font-weight: 400">FDA grants emergency authorization to drug for coronavirus; White House blocks Fauci from testifying before House subcommittee</span></a><span style="font-weight: 400">, 2 Mayıs 2020</span></p>
<p>TÜBİTAK, <a href="https://web.archive.org/web/20200507111614/https://covid19.tubitak.gov.tr/">Covid-19 Türkiye Portalı</a></p>
<p><span style="font-weight: 400">University of Oxford, </span><a href="https://web.archive.org/web/20200507111614/http://www.ox.ac.uk/news/2020-04-23-oxford-covid-19-vaccine-begins-human-trial-stage"><span style="font-weight: 400">Oxford COVID-19 vaccine begins human trial stage</span></a><span style="font-weight: 400">, 23 Nisan 2020</span></p>
<p><span style="font-weight: 400">Vaccines Europe, </span><a href="https://web.archive.org/web/20200507111614/https://www.vaccineseurope.eu/about-vaccines/how-are-vaccines-developed"><span style="font-weight: 400">How are vaccines developed?</span></a></p>
<p><span style="font-weight: 400">WHO, </span><a href="https://web.archive.org/web/20200507111614/https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines"><span style="font-weight: 400">Draft landscape of COVID 19 candidate vaccines</span></a><span style="font-weight: 400">, 30 Nisan 2020</span></p>
<p><span style="font-weight: 400">WHO, </span><a href="https://web.archive.org/web/20200507111614/https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments"><span style="font-weight: 400">“Solidarity” clinical trial for COVID-19 treatments</span></a></p>
<p><strong><em>Kapak Görseli:</em></strong> Laura Kammermann</p>
</div>
<div class="cb-sticky-sidebar"><aside class="cb-sidebar clearfix"><div id="cb-recent-posts-4" class="cb-sidebar-widget cb-widget-latest-articles"><h3 class="cb-sidebar-widget-title cb-widget-title">#teyitpedia</h3>
<div class="cb-module-block cb-small-margin">
<article class="cb-looper cb-article cb-article-small cb-separated clearfix post-36663 post type-post status-publish format-standard has-post-thumbnail hentry category-teyitpedia tag-koronavirus tag-yanlis-bilgi">
<div class="cb-mask cb-img-fw">
<a href="https://web.archive.org/web/20200507111614/https://teyit.org/koronavirus-yanlis-bilgi-ureten-ve-yayan-yedi-insan-tipi/"><img width="100" height="65" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/yanlis-bilgi-ureten-ve-yayan-yedi-insan-tipi-100x65.png" class="attachment-cb-100-65 size-cb-100-65 wp-post-image" alt="" srcset="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/yanlis-bilgi-ureten-ve-yayan-yedi-insan-tipi-100x65.png 100w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/yanlis-bilgi-ureten-ve-yayan-yedi-insan-tipi-260x170.png 260w" sizes="(max-width: 100px) 100vw, 100px"/></a> </div>
<div class="cb-meta cb-article-meta">
<h4 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/koronavirus-yanlis-bilgi-ureten-ve-yayan-yedi-insan-tipi/">Koronavirüs: Yanlış bilgi üreten ve yayan yedi insan tipi</a></h4>
<div class="cb-byline cb-byline-short cb-byline-date"><span class="cb-date"><time class="updated" datetime="2020-05-07">07/05/2020</time></span></div> </div>
</article>
<article class="cb-looper cb-article cb-article-small cb-separated clearfix post-36461 post type-post status-publish format-standard has-post-thumbnail hentry category-teyitpedia tag-arastirma tag-koronavirus tag-yanlis-bilgi">
<div class="cb-mask cb-img-fw">
<a href="https://web.archive.org/web/20200507111614/https://teyit.org/arastirma-uzmanlar-koronavirusle-ilgili-yanlis-bilgilerle-mucadelede-ne-oneriyor/"><img width="100" height="65" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/arastirma-uzmanlar-koronavirusle-ilgili-yanlis-bilgilerle-mucadele-ne-oneriyor-100x65.png" class="attachment-cb-100-65 size-cb-100-65 wp-post-image" alt="" srcset="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/arastirma-uzmanlar-koronavirusle-ilgili-yanlis-bilgilerle-mucadele-ne-oneriyor-100x65.png 100w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/05/arastirma-uzmanlar-koronavirusle-ilgili-yanlis-bilgilerle-mucadele-ne-oneriyor-260x170.png 260w" sizes="(max-width: 100px) 100vw, 100px"/></a> </div>
<div class="cb-meta cb-article-meta">
<h4 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/arastirma-uzmanlar-koronavirusle-ilgili-yanlis-bilgilerle-mucadelede-ne-oneriyor/">Araştırma: Uzmanlar koronavirüsle ilgili yanlış bilgilerle mücadelede ne öneriyor?</a></h4>
<div class="cb-byline cb-byline-short cb-byline-date"><span class="cb-date"><time class="updated" datetime="2020-05-02">02/05/2020</time></span></div> </div>
</article>
<article class="cb-looper cb-article cb-article-small cb-separated clearfix post-36360 post type-post status-publish format-standard has-post-thumbnail hentry category-teyitpedia category-politika tag-multeci tag-polis">
<div class="cb-mask cb-img-fw">
<a href="https://web.archive.org/web/20200507111614/https://teyit.org/medya-alinin-gercek-hikayesini-neden-aktaramadi/"><img width="100" height="65" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/medya-neden-ali’nin-gercek-hikayesini-aktaramadi-100x65.jpg" class="attachment-cb-100-65 size-cb-100-65 wp-post-image" alt="" srcset="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/medya-neden-ali’nin-gercek-hikayesini-aktaramadi-100x65.jpg 100w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/medya-neden-ali’nin-gercek-hikayesini-aktaramadi-260x170.jpg 260w" sizes="(max-width: 100px) 100vw, 100px"/></a> </div>
<div class="cb-meta cb-article-meta">
<h4 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/medya-alinin-gercek-hikayesini-neden-aktaramadi/">Medya Ali’nin gerçek hikayesini neden aktaramadı?</a></h4>
<div class="cb-byline cb-byline-short cb-byline-date"><span class="cb-date"><time class="updated" datetime="2020-04-30">30/04/2020</time></span></div> </div>
</article>
<article class="cb-looper cb-article cb-article-small cb-separated clearfix post-36299 post type-post status-publish format-standard has-post-thumbnail hentry category-teyitpedia tag-5g tag-koronavirus">
<div class="cb-mask cb-img-fw">
<a href="https://web.archive.org/web/20200507111614/https://teyit.org/5g-ile-yeni-koronavirus-arasinda-bag-oldugu-iddialari-twitterda-nasil-yayildi/"><img width="100" height="65" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/5g-ile-yeni-koronavirus-arasinda-bag-oldugu-iddialari-twitterda-nasil-yayildi-1-100x65.png" class="attachment-cb-100-65 size-cb-100-65 wp-post-image" alt="" srcset="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/5g-ile-yeni-koronavirus-arasinda-bag-oldugu-iddialari-twitterda-nasil-yayildi-1-100x65.png 100w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/5g-ile-yeni-koronavirus-arasinda-bag-oldugu-iddialari-twitterda-nasil-yayildi-1-260x170.png 260w" sizes="(max-width: 100px) 100vw, 100px"/></a> </div>
<div class="cb-meta cb-article-meta">
<h4 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/5g-ile-yeni-koronavirus-arasinda-bag-oldugu-iddialari-twitterda-nasil-yayildi/">5G ile yeni koronavirüs arasında bağ olduğu iddiaları Twitter’da nasıl yayıldı?</a></h4>
<div class="cb-byline cb-byline-short cb-byline-date"><span class="cb-date"><time class="updated" datetime="2020-04-30">30/04/2020</time></span></div> </div>
</article>
<article class="cb-looper cb-article cb-article-small cb-separated clearfix post-36124 post type-post status-publish format-standard has-post-thumbnail hentry category-teyitpedia tag-oxford-universitesi tag-reuters-gazetecilik-calismalari-enstitusu tag-yanlis-bilgi">
<div class="cb-mask cb-img-fw">
<a href="https://web.archive.org/web/20200507111614/https://teyit.org/arastirma-koronavirusle-ilgili-bilgi-edinmek-icin-en-cok-cevrimici-ortamlara-basvuruluyor/"><img width="100" height="65" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/covid-19-ile-ilgili-bilgi-edinmek-icin-en-cok-cevrimici-ortamlara-basvuruluyor-100x65.png" class="attachment-cb-100-65 size-cb-100-65 wp-post-image" alt="" srcset="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/covid-19-ile-ilgili-bilgi-edinmek-icin-en-cok-cevrimici-ortamlara-basvuruluyor-100x65.png 100w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/covid-19-ile-ilgili-bilgi-edinmek-icin-en-cok-cevrimici-ortamlara-basvuruluyor-260x170.png 260w" sizes="(max-width: 100px) 100vw, 100px"/></a> </div>
<div class="cb-meta cb-article-meta">
<h4 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/arastirma-koronavirusle-ilgili-bilgi-edinmek-icin-en-cok-cevrimici-ortamlara-basvuruluyor/">Araştırma: Koronavirüsle ilgili bilgi edinmek için en çok çevrimiçi ortamlara başvuruluyor</a></h4>
<div class="cb-byline cb-byline-short cb-byline-date"><span class="cb-date"><time class="updated" datetime="2020-04-25">25/04/2020</time></span></div> </div>
</article>
<article class="cb-looper cb-article cb-article-small cb-separated clearfix post-35758 post type-post status-publish format-standard has-post-thumbnail hentry category-teyitpedia tag-koronavirus tag-rapor tag-teyit tag-vircon-group">
<div class="cb-mask cb-img-fw">
<a href="https://web.archive.org/web/20200507111614/https://teyit.org/rapor-covid-19-dijital-platformlarda-haber-alma-aliskanliklarimizi-nasil-degistirdi/"><img width="100" height="65" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/rapor-covid-19-dijital-platformlarda-haber-alma-aliskanliklarimizi-nasil-degistirdi-100x65.png" class="attachment-cb-100-65 size-cb-100-65 wp-post-image" alt="" srcset="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/rapor-covid-19-dijital-platformlarda-haber-alma-aliskanliklarimizi-nasil-degistirdi-100x65.png 100w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/rapor-covid-19-dijital-platformlarda-haber-alma-aliskanliklarimizi-nasil-degistirdi-260x170.png 260w" sizes="(max-width: 100px) 100vw, 100px"/></a> </div>
<div class="cb-meta cb-article-meta">
<h4 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/rapor-covid-19-dijital-platformlarda-haber-alma-aliskanliklarimizi-nasil-degistirdi/">Rapor: Covid-19 dijital platformlarda haber alma alışkanlıklarımızı nasıl değiştirdi?</a></h4>
<div class="cb-byline cb-byline-short cb-byline-date"><span class="cb-date"><time class="updated" datetime="2020-04-21">21/04/2020</time></span></div> </div>
</article>
<article class="cb-looper cb-article cb-article-small cb-separated clearfix post-35778 post type-post status-publish format-standard has-post-thumbnail hentry category-teyitpedia tag-koronavirus tag-reuters-gazetecilik-calismalari-enstitusu tag-yanlis-bilgi">
<div class="cb-mask cb-img-fw">
<a href="https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-yanlis-bilgi-turleri-kaynaklari-ve-iddialari/"><img width="100" height="65" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/covid-19-yanlis-bilgi-turleri-kaynaklari-ve-iddialari-100x65.png" class="attachment-cb-100-65 size-cb-100-65 wp-post-image" alt="" srcset="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/covid-19-yanlis-bilgi-turleri-kaynaklari-ve-iddialari-100x65.png 100w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/04/covid-19-yanlis-bilgi-turleri-kaynaklari-ve-iddialari-260x170.png 260w" sizes="(max-width: 100px) 100vw, 100px"/></a> </div>
<div class="cb-meta cb-article-meta">
<h4 class="cb-post-title"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/covid-19-yanlis-bilgi-turleri-kaynaklari-ve-iddialari/">Covid-19: Yanlış bilgi türleri, kaynakları ve iddiaları</a></h4>
<div class="cb-byline cb-byline-short cb-byline-date"><span class="cb-date"><time class="updated" datetime="2020-04-17">17/04/2020</time></span></div> </div>
</article>
</div>
</div> <div id="media_image-6" class="cb-sidebar-widget widget_media_image"><h3 class="cb-sidebar-widget-title cb-widget-title">Editör Masası</h3><a href="https://web.archive.org/web/20200507111614/https://teyit.org/editormasasi"><img width="300" height="300" src="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/Editör-Masası-300x300.jpg" class="image wp-image-7988  attachment-medium size-medium" alt="" style="max-width: 100%; height: auto;" srcset="https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/Editör-Masası-300x300.jpg 300w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/Editör-Masası-150x150.jpg 150w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/Editör-Masası-125x125.jpg 125w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/Editör-Masası-45x45.jpg 45w, https://web.archive.org/web/20200507111614im_/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2016/10/Editör-Masası.jpg 465w" sizes="(max-width: 300px) 100vw, 300px"/></a></div><div id="text-18" class="cb-sidebar-widget widget_text"><h3 class="cb-sidebar-widget-title cb-widget-title">Tarafsızlık beyanı</h3> <div class="textwidget"><p><a title="IFCN signatory" href="https://web.archive.org/web/20200507111614/https://ifcncodeofprinciples.poynter.org/application/public/teyit/8D8FD76F-9968-9B15-8BEE-D2046F59BC89" target="_blank" rel="noopener noreferrer"><br/>
<img style="max-width: 100%;" src="https://web.archive.org/web/20200507111614im_/https://cdn.ifcncodeofprinciples.poynter.org/storage/badges/91B22AA2-4052-3973-E1EE-A7FB61B2FA2F.png"/><br/>
</a><br/>
<em>Bu arma, teyit.org’un organizasyonel ve editoryal süreçlerinin <a href="https://web.archive.org/web/20200507111614/https://www.poynter.org/international-fact-checking-network-fact-checkers-code-principles">Uluslararası Doğruluk Kontrolü Ağı</a>’nın prensipleriyle uyuştuğunu göstermektedir. teyit.org, çalışmalarında tarafsız olduğunu, hakkaniyetli davrandığını, kaynaklarının, finansal yapısının ve organizasyonunun şeffaf olduğunu, metodolojisinin herkese açık şekilde paylaşıldığını ve düzeltme politikasını yayımladığını Ağ’ın yönetim kuruluna ve bağımsız değerlendiriciye ispat ederek İlkeler Kılavuzu’nun imzacısı olmaya ve bu armayı sitesine yerleştirmeye hak kazanmıştır.</em></p>
</div>
</div></aside>
</div>
</div>
</div> 
</div> 
<footer id="cb-footer">
<div id="cb-widgets" class="cb-footer-x cb-footer-a wrap clearfix cb-site-padding">
<div class="cb-one cb-column clearfix">
<div id="text-2" class="cb-footer-widget clearfix widget_text"><h3 class="cb-footer-widget-title cb-widget-title">Nedir?</h3> <div class="textwidget">teyit.org internette yer alan şüpheli bilgileri tarayan, seçen, araştıran ve analiz haline getirerek okura sunan bir doğrulama platformudur.</div>
</div> </div>
<div class="cb-two cb-column clearfix">
<div id="text-4" class="cb-footer-widget clearfix widget_text"><h3 class="cb-footer-widget-title cb-widget-title">E-posta Aboneliği</h3> <div class="textwidget">
<div id="mc_signup_form">
<form action="//web.archive.org/web/20200507111614/https://teyit.us14.list-manage.com/subscribe/post?u=df349df68aaf332204524fb4c&amp;id=a1a05cc2f1" method="post" id="mc-embedded-subscribe-form" name="mc-embedded-subscribe-form" class="validate" target="_blank" novalidate>
<div id="mc_embed_signup_scroll">
<div class="mc-field-group">
<input type="email" value="" name="EMAIL" class="required email mc_input" id="mce-EMAIL">
</div>
<div id="mce-responses" class="clear">
<div class="response" id="mce-error-response" style="display:none"></div>
<div class="response" id="mce-success-response" style="display:none"></div>
</div> 
<div style="position: absolute; left: -5000px;" aria-hidden="true"><input type="text" name="b_df349df68aaf332204524fb4c_a1a05cc2f1" tabindex="-1" value=""></div>
<div class="clear"><input type="submit" value="Abone Ol" name="subscribe" id="mc_signup_submit" class="button"></div>
</div>
</form>
</div>
<script data-cfasync="false" src="/web/20200507111614js_/https://teyit.org/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="‘text/javascript’" src="/web/20200507111614js_/https://teyit.org/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/‘/s3.amazonaws.com/downloads.mailchimp.com/js/mc-validate.js’"></script><script type="‘text/javascript’">(function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]=‘EMAIL’;ftypes[0]=‘email’;fnames[1]=‘FNAME’;ftypes[1]=‘text’;fnames[2]=‘LNAME’;ftypes[2]=‘text’; /*
* Translated default messages for the $ validation plugin.
* Locale: TR
*/
$.extend($.validator.messages, {
    required: "Bu alanın doldurulması zorunludur.",
    remote: "Lütfen bu alanı düzeltin.",
    email: "Lütfen geçerli bir e-posta adresi giriniz.",
    url: "Lütfen geçerli bir web adresi (URL) giriniz.",
    date: "Lütfen geçerli bir tarih giriniz.",
    dateISO: "Lütfen geçerli bir tarih giriniz(ISO formatında)",
    number: "Lütfen geçerli bir sayı giriniz.",
    digits: "Lütfen sadece sayısal karakterler giriniz.",
    creditcard: "Lütfen geçerli bir kredi kartı giriniz.",
    equalTo: "Lütfen aynı değeri tekrar giriniz.",
    accept: "Lütfen geçerli uzantıya sahip bir değer giriniz.",
    maxlength: $.validator.format("Lütfen en fazla {0} karakter uzunluğunda bir değer giriniz."),
    minlength: $.validator.format("Lütfen en az {0} karakter uzunluğunda bir değer giriniz."),
    rangelength: $.validator.format("Lütfen en az {0} ve en fazla {1} uzunluğunda bir değer giriniz."),
    range: $.validator.format("Lütfen {0} ile {1} arasında bir değer giriniz."),
    max: $.validator.format("Lütfen {0} değerine eşit ya da daha küçük bir değer giriniz."),
    min: $.validator.format("Lütfen {0} değerine eşit ya da daha büyük bir değer giriniz.")
});}(jQuery));var $mcj = jQuery.noConflict(true);</script>
</div>
</div> </div>
<div class="cb-three cb-column clearfix">
<div id="cb-social-media-widget-2" class="cb-footer-widget clearfix cb-widget-social-media clearfix"><h3 class="cb-footer-widget-title cb-widget-title">Takip Et!</h3><div class="cb-social-media-icons cb-white"><a href="https://web.archive.org/web/20200507111614/https://instagram.com/teyitorg" target="_blank" class="cb-instagram cb-icon-1"></a><a href="https://web.archive.org/web/20200507111614/https://youtube.com/teyitorg" target="_blank" class="cb-youtube cb-icon-2"></a></div></div> </div>
</div>
<div class="cb-footer-lower cb-font-header clearfix">
<div class="wrap clearfix">
<div class="cb-footer-links clearfix"><ul id="menu-ust-1" class="nav cb-footer-nav clearfix"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-338"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/nedir/">Nedir?</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-337"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/yayin-ilkeleri-ve-metodoloji/">Yayın İlkeleri ve Metodoloji</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-336"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/ekip/">Ekip</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-335"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/iletisim/">İletişim</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-946"><a href="https://web.archive.org/web/20200507111614/https://teyit.org/eng/">ENGLISH</a></li>
</ul></div>
<div class="cb-copyright">© 2020 teyit.org, Her Hakkı Saklıdır.
<p><a href="https://web.archive.org/web/20200507111614/https://teyit.org/kullanim-kosullari-ve-gizlilik-politikasi/">Kullanım Koşulları ve Gizlilik Sözleşmesi</a></p>
<p><a href="https://web.archive.org/web/20200507111614/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/03/Teyit_KVKK-Başvuru-Formu_2020.docx">KVKK Başvuru Formu</a></p>
<p><a href="https://web.archive.org/web/20200507111614/https://teyit.fra1.cdn.digitaloceanspaces.com/wp-content/uploads/2020/03/Teyit_Çerez-Politikası_2020.pdf">Çerez Politikası</a></p>
</div>
<div class="cb-to-top"><a href="#" id="cb-to-top"><i class="fa fa-angle-up cb-circle"></i></a></div>
</div>
</div>
</footer> 
</div> 
<span id="cb-overlay"></span>
<input type="hidden" id="_zinenonce" name="_zinenonce" value="4995492be8"/><input type="hidden" name="_wp_http_referer" value="/covid-19-tedavisinde-denenen-ilac-ve-asi-calismalari-ne-durumda/"/> <div style="display:none">
<div class="grofile-hash-map-b87ff1754a7aefa1fe7a119fdaa699ce">
</div>
</div>
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://web.archive.org/web/20200507111614/https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-85970084-1', 'auto');
  ga('send', 'pageview');

</script>

<script>
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;
n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
document,'script','https://web.archive.org/web/20200507111614/https://connect.facebook.net/en_US/fbevents.js');
fbq('init', '1967505976836989');
fbq('track', 'PageView');
</script>
<noscript><img height="1" width="1" style="display:none" src="https://web.archive.org/web/20200507111614im_/https://www.facebook.com/tr?id=1967505976836989&amp;ev=PageView&amp;noscript=1"/></noscript>


<script>
jQuery(document).ready(function($){
   $('.wpvq-true').text('Doğru Cevap!');
$('.wpvq-false').text('Yanlış Cevap!');
}); 
</script><script data-cfasync="false" type="text/javascript">if (window.addthis_product === undefined) { window.addthis_product = "wpwt"; } if (window.wp_product_version === undefined) { window.wp_product_version = "wpwt-3.2.3"; } if (window.wp_blog_version === undefined) { window.wp_blog_version = "5.2.6"; } if (window.addthis_share === undefined) { window.addthis_share = {"passthrough":{"twitter":{"via":"teyitorg"}}}; } if (window.addthis_config === undefined) { window.addthis_config = {"data_track_clickback":true,"ui_atversion":"300"}; } if (window.addthis_plugin_info === undefined) { window.addthis_plugin_info = {"info_status":"enabled","cms_name":"WordPress","plugin_name":"Website Tools by AddThis","plugin_version":"3.2.3","plugin_mode":"AddThis","anonymous_profile_id":"wp-dfff1a68efb676e9140c4d9d18abc3fc","page_info":{"template":"posts","post_type":""},"sharing_enabled_on_post_via_metabox":false}; } 
                    (function() {
                      var first_load_interval_id = setInterval(function () {
                        if (typeof window.addthis !== 'undefined') {
                          window.clearInterval(first_load_interval_id);
                          if (typeof window.addthis_layers !== 'undefined' && Object.getOwnPropertyNames(window.addthis_layers).length > 0) {
                            window.addthis.layers(window.addthis_layers);
                          }
                          if (Array.isArray(window.addthis_layers_tools)) {
                            for (i = 0; i < window.addthis_layers_tools.length; i++) {
                              window.addthis.layers(window.addthis_layers_tools[i]);
                            }
                          }
                        }
                     },1000)
                    }());
                </script><script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://s7.addthis.com/js/300/addthis_widget.js?ver=5.2.6#pubid=ra-5a70378ec24243c7"></script>
<script type="text/javascript">
/* <![CDATA[ */
var wpcf7 = {"apiSettings":{"root":"https:\/\/web.archive.org\/web\/20200507111614\/https:\/\/teyit.org\/wp-json\/contact-form-7\/v1","namespace":"contact-form-7\/v1"},"recaptcha":{"messages":{"empty":"L\u00fctfen robot olmad\u0131\u011f\u0131n\u0131z\u0131 do\u011frulay\u0131n."}}};
/* ]]> */
</script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/plugins/contact-form-7/includes/js/scripts.js?ver=5.0.4"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://s0.wp.com/wp-content/js/devicepx-jetpack.js?ver=202019"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/themes/15zine-child/scripts/inview.js?ver=1.1"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/themes/15zine-child/scripts/pixelate.js?ver=1.1"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/themes/15zine-child/scripts/countup.js?ver=1.1"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://apis.google.com/js/platform.js?ver=1.1"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/themes/15zine-child/scripts/scripts.js?ver=1.3.17"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/themes/15zine/library/js/cookie.min.js?ver=3.1.2"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-includes/js/comment-reply.min.js?ver=5.2.6"></script>
<script type="text/javascript">
/* <![CDATA[ */
var cbExt = {"cbLb":"on"};
/* ]]> */
</script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/themes/15zine/library/js/cb-ext.js?ver=3.1.2"></script>
<script type="text/javascript">
/* <![CDATA[ */
var cbScripts = {"cbUrl":"https:\/\/web.archive.org\/web\/20200507111614\/https:\/\/teyit.org\/wp-admin\/admin-ajax.php","cbPostID":"36498","cbFsClass":"cb-embed-fs","cbSlider":["600",true,"7000","on"],"cbALlNonce":"578b6c4b29","cbPlURL":"https:\/\/web.archive.org\/web\/20200507111614\/https:\/\/teyit.org\/wp-content\/plugins","cbShortName":null};
/* ]]> */
</script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/themes/15zine/library/js/cb-scripts.min.js?ver=3.1.2"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-includes/js/wp-embed.min.js?ver=5.2.6"></script>
<script async="async" type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://teyit.org/wp-content/plugins/akismet/_inc/form.js?ver=4.1.2"></script>
<script type="text/javascript" src="https://web.archive.org/web/20200507111614js_/https://stats.wp.com/e-202019.js" async="async" defer="defer"></script>
<script type="text/javascript">
	_stq = window._stq || [];
	_stq.push([ 'view', {v:'ext',j:'1:7.3.1',blog:'118063973',post:'36498',tz:'3',srv:'teyit.org'} ]);
	_stq.push([ 'clickTrackerInit', '118063973', '36498' ]);
</script>
</body>
</html> 
<!--
     FILE ARCHIVED ON 11:16:14 May 07, 2020 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 05:45:31 Jul 29, 2021.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  captures_list: 214.326
  exclusion.robots: 0.242
  exclusion.robots.policy: 0.235
  RedisCDXSource: 1.641
  esindex: 0.008
  LoadShardBlock: 194.424 (3)
  PetaboxLoader3.datanode: 106.917 (4)
  CDXLines.iter: 15.791 (3)
  load_resource: 192.747
  PetaboxLoader3.resolve: 147.965
-->